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ABSTARCT

COMPUTER AIDED DIAGNOSIS SYSTEM FOR BREAST CANCER USING DEEP
LEARNING
Asma Baccouche
July 25, 2022
The recent rise of big data technology surrounding the electronic systems and developed toolkits
gave birth to new promises for Artificial Intelligence (AI). With the continuous use of data-centric systems
and machines in our lives, such as social media, surveys, emails, reports, etc., there is no doubt that data has
gained the center of attention by scientists and motivated them to provide more decision-making and
operational support systems across multiple domains.
With the recent breakthroughs in artificial intelligence, the use of machine learning and deep
learning models have achieved remarkable advances in computer vision, ecommerce, cybersecurity, and
healthcare. Particularly, numerous applications provided efficient solutions to assist radiologists and doctors
for medical imaging analysis, which has remained the essence of the visual representation that is used to
construct the final observation and diagnosis.
Medical research in cancerology and oncology has been recently blended with the knowledge gained
from computer engineering and data science experts. In this context, an automatic assistance or commonly
known as Computer-aided Diagnosis (CAD) system has become a popular area of research and development
in the last decades. As a result, the CAD systems have been developed using multidisciplinary knowledge
and expertise and they have been used to analyze the patient information to assist clinicians and practitioners
in their decision-making process. Treating and preventing cancer remains a crucial task that radiologists and
oncologists face every day to detect and investigate abnormal tumors. Therefore, a CAD system could be
developed to provide decision support for many applications in the cancer patient care processes, such as
lesion detection, characterization, cancer staging, tumors assessment, recurrence, and prognosis prediction.
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Breast cancer has been considered one of the common types of cancers in females across the world.
It was also considered the leading cause of mortality among women, and it has been increased drastically
every year. Early detection and diagnosis of abnormalities in screened breasts has been acknowledged as the
optimal solution to examine the risk of developing breast cancer and thus reduce the increasing mortality
rate.
Accordingly, this dissertation proposes a new state-of-the-art CAD system for breast cancer
diagnosis that is based on deep learning technology and cutting-edge computer vision techniques.
Mammography screening has been recognized as the most effective tool to early detect breast lesions for
reducing the mortality rate. It helps reveal abnormalities in the breast such as Mass lesion, Architectural
Distortion, Microcalcification. With the number of daily patients that were screened is continuously
increasing, having a second reading tool or assistance system could leverage the process of breast cancer
diagnosis. Mammograms could be obtained using different modalities such as X-ray scanner and Full-Field
Digital mammography (FFDM) system. The quality of the mammograms, the characteristics of the breast
(i.e., density, size) or/and the tumors (i.e., location, size, shape) could affect the final diagnosis. Therefore,
radiologists could miss the lesions and consequently they could generate false detection and diagnosis.
Therefore, this work was motivated to improve the reading of mammograms in order to increase the accuracy
of the challenging tasks.
The efforts presented in this work consists of new design and implementation of neural network
models for a fully integrated CAD system dedicated to breast cancer diagnosis. The approach is designed to
automatically detect and identify breast lesions from the entire mammograms at a first step using fusion
models’ methodology. Then, the second step only focuses on the Mass lesions and thus the proposed system
should segment the detected bounding boxes of the Mass lesions to mask their background. A new neural
network architecture for mass segmentation was suggested that was integrated with a new data enhancement
and augmentation technique. Finally, a third stage was conducted using a stacked ensemble of neural
networks for classifying and diagnosing the pathology (i.e., malignant, or benign), the Breast Imaging
Reporting and Data System (BI-RADS) assessment score (i.e., from 2 to 6), or/and the shape (i.e., round,
oval, lobulated, irregular) of the segmented breast lesions.
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Another contribution was achieved by applying the first stage of the CAD system for a retrospective analysis
and comparison of the model on Prior mammograms of a private dataset. The work was conducted by joining
the learning of the detection and classification model with the image-to-image mapping between Prior and
Current screening views.
Each step presented in the CAD system was evaluated and tested on public and private datasets and
consequently the results have been fairly compared with benchmark mammography datasets. The integrated
framework for the CAD system was also tested for deployment and showcase. The performance of the CAD
system for the detection and identification of breast masses reached an overall accuracy of 97%. The
segmentation of breast masses was evaluated together with the previous stage and the approach achieved an
overall performance of 92%. Finally, the classification and diagnosis step that defines the outcome of the
CAD system reached an overall pathology classification accuracy of 96%, a BIRADS categorization
accuracy of 93%, and a shape classification accuracy of 90%. Results given in this dissertation indicate that
our suggested integrated framework might surpass the current deep learning approaches by using all the
proposed automated steps. Limitations of the proposed work could occur on the long training time of the
different methods which is due to the high computation of the developed neural networks that have a huge
number of the trainable parameters.
Future works can include new orientations of the methodologies by combining different
mammography datasets and improving the long training of deep learning models. Moreover, motivations
could upgrade the CAD system by using annotated datasets to integrate more breast cancer lesions such as
Calcification and Architectural distortion.
The proposed framework was first developed to help detect and identify suspicious breast lesions in
X-ray mammograms. Next, the work focused only on Mass lesions and segment the detected ROIs to remove
the tumor’s background and highlight the contours, the texture, and the shape of the lesions. Finally, the
diagnostic decision was predicted to classify the pathology of the lesions and investigate other characteristics
such as the tumors’ grading assessment and type of the shape.
The dissertation presented a CAD system to assist doctors and experts to identify the risk of breast
cancer presence. Overall, the proposed CAD method incorporates the advances of image processing, deep
learning, and image-to-image translation for a biomedical application.
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CHAPTER I
INTRODUCTION

A. Breast Cancer
In recent decades, cancer diseases have occurred in many cases worldwide and the global number
is predicted to grow to 27.5 million new cases by 2040 [1]. Cancer is described by the uncontrolled growth
of abnormal cells within the body. There are quite 100 different types of cancer diseases which will occur
anywhere within the body, but they are mainly described in five categories: carcinomas (i.e., skin and tissues
affecting the inner organs), sarcomas (i.e., muscles, bones, or cartilage), leukemia (i.e., blood and bone
marrow), lymphomas (i.e., immune system), and central nervous system (i.e., brain and spinal cord) [2]. Most
commonly, lung cancer and prostate cancer occur in men, and breast cancer occurs in women.
Over years, breast cancer has remained the foremost frequently diagnosed non-skin cancer and
therefore the leading explanation for death among females with a rate of 32% of total cancer cases [3].
According to the American Cancer Society, it is estimated that over 290,000 new cases will be reported, and
43,780 women will die from breast cancer in 2022 [4]. Early detection and diagnosis of breast cancer is the
most effective way to treat this disease and reduce the mortality rate [5].
Breast cancer starts at the breast and replicates abnormal cells into lumps, often called tumors, as
shown in Figure 1. Certain factors can increase the risk of developing the disease like aging and genetics [6].
The tumor can be classified as malignant or benign. While benign tumors are considered non-cancerous, the
risk of malignant tumors must be studied before being spread into other health organs such as bones, lungs,
liver, and adrenal gland [7]. Consequently, early detection and diagnosis of breast cancer has become required
to reduce the high mortality rate among women; thus, diagnostic systems have been studied to help
radiologists with more precise analysis [8-11].
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FIGURE 1: Breast composition in case of metastatic breast cancer
Source: https://www.cancersupportcommunity.org/metastatic-breast-cancer

B. Mammography
Since the invention of X-rays, medical imaging has significantly affected the cancerology. Over the
last decades, a variety of imaging modalities and techniques have contributed to the screening process such
as the computed tomography (CT), the ultrasonography, the magnetic resonance imaging (MRI), and the
digital radiography [12]. Consequently, medical imaging has played a very important role within the
diagnosis for acquiring medical images that are presented to radiology experts for interpretation and
investigation as shown in Figure 2.
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FIGURE 2: Medical imaging for investigating and screening of breast lesions
Source; https://nypost.com/2019/09/03/breast-cancer-treatment-could-lead-to-incurable-tumors-years-later/

Mammography has been proven the most reliable and preferred tool employed by radiologists to screen
and investigate suspicious breast lesions [13]. The common clinical modalities that have been used since the
2000s are the real-time 3D ultrasound imaging, 2D and 3D cone-beam CT and full-field digital
mammography (FFDM). The techniques are categorized into film-screen mammography, which creates a
scanned photographic film, and digital mammography. Particularly, the FFDM method replaces the X-ray
films by electronics and creates digital images. The general process of screening takes a few moments and
uses a low-dose X-ray system to see inside the breasts and visualize any abnormal clusters and irregular
nodules. The patient having the mammogram places their breast between two clear plates to be squeezed and
scanned into digital images [14] as illustrated in Figure 3. The machine should take a picture from two angles
for bilateral comparison into a mediolateral oblique (MLO) view and craniocaudal (CC) view. Correct
positioning is critical to capture the whole breast and find out any abnormal regions.
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FIGURE 3: Mammography screening process

Mammograms visualize the whole breast tissue on the MLO projection on a single image where the
nipple should be well-positioned at the lower level of the pectoralis major. The CC view should show the
medial tissue without the axillary tail of the breast and with a pectoralis major situated at the center of the
view. Samples of mammograms from MLO and CC views are demonstrated in Figure 4 and Figure 5.

FIGURE 4: Samples mammograms of Mediolateral oblique (MLO) views
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FIGURE 5: Samples mammograms of craniocaudal (CC) views

Radiologists should visually detect any area that does not look like normal tissue and may be a clear
indicator of a cancer risk. During the diagnosis, the experts often search for areas of white, their position in
the breast and note the density of the fatty tissue or/and the shape and size of the breast. A main concern
taken from an observation occurs when a lump of a clear tumor appears as a condensed white area on a
mammogram. A malignant tumor is likely to grow and change shape into a mass lesion. However, a benign
tumor is usually non-cancerous and does not present a health risk and it is unlikely to grow. Other forms of
irregular tissue can appear in the form of white spots and dots, and they are usually harmless. However, a
continuous follow-up is required to track their shape and pattern that may lead to a sign of cancer. These
abnormalities include calcification, asymmetry, architectural distortion, etc. Most of the non-mass lesions are
benign and caused by summation of artifacts [15]. Samples below in Figure 6 present examples of
mammograms that belong to public and private mammography datasets, and they were acquired using
different modalities such as FFDM and digital mammographic screening.
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FIGURE 6: Samples mammograms with Mass lesions (first row) and with Calcification lesions (second row)

It is clear in Figure 6 that mammograms look different because they have different resolution and
capture quality due to the different modality that was used to extract and save the images. Every mammogram
may indicate one or more lesions of varying sizes and locations. Samples below present examples of different
breast lesions that are commonly inspected in mammograms. Radiologists often investigate different
screening views at different times and make a comparison to spot any unusual change or verify any suspected
symptoms of breast cancer the patient has noticed.
Figure 7 shows samples of breast Mass lesions. Breast mass is a nodule or growth of tissue with
defined borders. It is often characterized with a firm and hard area that causes a change in the tissue, the
color, the size, or the density of the breast. A breast mass may be benign (non-cancerous) or malignant
(harmful). A breast tumor can be confirmed with the feel (i.e., firm, margin, squishy, mobile), with
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appearance in mammograms (i.e., fuzzy, lumpy, round, uniform), in an MRI (rapid or slow to light up), or
with a biopsy (i.e., clusters of cells, irregular nuclei).

FIGURE 7: Samples of region of interest (ROI) OF breast Mass lesions from public and private datasets

Moreover, non-cancerous breast lesions like calcification and architectural distortion are shown in
Figure 8 and Figure 9. Calcifications are often small deposits of calcium that are manifested in the form of
white spots and dots. During the mammography, this built-up calcium absorbs the X-rays and shows up as a
bright marker as shown in samples of Figure 8. Calcifications are not associated with breast cancer, and they
are eventually benign cells, however they may be associated with presence of ductal carcinoma in situ [16].
Studies showed that a large calcification, known as macro calcification, is less specious. They should appear
well-defined as dots and specks. On the other side, micro-calcifications are smaller and resemble mini flecks,
but they require more follow-up.
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FIGURE 8: Samples of region of interest (ROI) OF breast Calcification lesions from public and private datasets

Other common harmless breast lesions are the architectural distortion that refers to clear distortion
of the breast lobule without defining mass [17]. As shown in Figure 9, these non-cancerous lesions often
appear as thin straight lines of spiculum in the form of dots, distortion, and focal retraction [18]. Architectural
distortion is the third most common breast lesion, and it may be associated with calcifications or asymmetry,
and it may represent an early indicator of breast cancer. Moreover, it is considered the hardest to diagnose,
particularly in 2D mammography as it appears in variable presentation, size, and location.
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FIGURE 9: Samples of region of interest (ROI) OF breast Architectural Distortion lesions from public and private
datasets

During the last decades, breast cancer reporting has been standardized using the Breast Imaging
Reporting and Data System (BI-RADS) that is universally used by radiologists and experts for risk
assessment and tumor grading. BI-RADS was developed by the American College of Radiology [19] that
scaled the diagnosis assessment with a score from 0 to 6. The score is commonly used in all screening
modalities to help determine the severity of the breast lesions and quantify the finding. It also contributes to
the tracking of change in breast lesions and classifies the growth of the lesions. Table 1 summarizes the
assessment categories and description.
Table 1: BI-RADS assessment categories

Category

Diagnosis assessment

0

Incomplete: Not enough information

1

Negative: No assessment

2

Benign

3

Probably benign: High probability of benign

4

Probably malignant: Reasonable probability of malignancy

5

High suggestive of malignancy

6

Known biopsy proven malignancy

Mammograms are used for detection and segmentation of abnormalities in the breast to remove the
tumors background and provide affordable diagnosis like the tumor’s pathology (i.e., malignant, or benign)
and classifying its shape and grading (i.e., BI-RADS score). Because most of these clinical tasks are usually
conducted manually, their precision and efficiency are usually associated with the radiologist’s expertise. In
fact, automated analysis of mammograms could enhance the reading and reduce the false detection and
decision towards the breast cancer diagnosis.

C. Artificial Intelligence and CAD systems for Breast Cancer
Studies emphasized the importance of frequent mammography screening to reduce the mortality
rate by early detecting the breast tumors before being spread to normal tissues and other healthy organs [20].
Therefore, mammograms are inspected every day by radiology experts to search for abnormal lesions and
detect the location, shape, and type of any suspicious regions in the breast [21]. Although this process is
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considered crucial and requires more precision and accuracy, it remains expensive and exposed to error, due
to the increasing number of daily-screened mammograms [22].
During the screening process, radiologists should detect the abnormal lesions; determine their
location on the breast mammogram, and identify their type to distinguish between mass, calcification, and
other common abnormalities. Another task the medical experts conduct is the image segmentation, which
helps doctors to extract detailed information of the suspicious regions of tumors for further diagnosis and
pathology findings. Finally, the doctors should make a final decision regarding the tumors and determine
their BI-RADS grading assessment and pathology diagnosis.
With the increase in the number of daily-screened mammograms, an efficient diagnostic
methodology is necessary to assist doctors in the timely procedure of breast cancer. Thus, computer-aided
diagnosis (CAD) systems could provide a second suggestion and reading to the final examination of the
experts regarding the presence of breast cancer [23]. The automated systems are designed to perform
computational image analysis and benefit from the high number of mammograms to handle the screening
process automatically [24].
In the last years, the advance of Artificial Intelligence (AI) in computer vision applications has
presented algorithms that showed remarkable results in developing tools to assist doctors. The systems could
handle detecting, segmenting, and classifying tumors with the lowest possible error in many medical image
applications and particularly in mammography [25, 26, 27].
Conventional systems relied on extracting hand-crafted and low-level features to localize and
classify potential regions using simple image processing and machine learning techniques [28, 29, 30]. So
far, these solutions have become inaccurate and resulted in a high false positive rate, and thus they have been
substituted with the novel deep learning approaches [31, 32, 33, 34]. Accordingly, traditional techniques for
tumor segmentation, such as region-growing, active contour, and watershed, relied on extracting handcrafted
features that only represent gray-level, texture, and morphology to label the pixels and indicate the contour
surrounding the mass tumors, while excluding the background tissue [35, 36]. Moreover, different algorithms
have been widely implemented in CAD systems for tumor classification, and the most used algorithms are
conventional machine learning classifiers and threshold-based methods that are based on handcrafted features
[35, 36, 37].
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With the continuous enhancement of computational capacity of computers, different deep learning
models have been widely implemented to offer a better alternative. They aim to automatically extract deep
and high-level features directly from raw images without knowledge requirement [38]. It has helped to
improve results of automated systems and maintain a good tradeoff between precision of lesions detection
and accuracy of distinguishing between different types of lesions from a single mammogram [39, 40, 41].
Deep learning algorithms can extract deep and multiple-scaled information and integrate them to help experts
in making final decisions. Accordingly, their strength to adapt to different cases has been proved for objects
detection and classification tasks in many applications [42, 43, 44, 45].
The development of computer-aided diagnosis (CAD) for breast cancer imaging has lately been
revised to deal with the rapid rise of deep learning algorithms and artificial intelligence, and it emphasizes
innovative systems that may have significant potential to improve clinical treatment [46, 47, 48].
With the practical challenges that breast tumors offer due to their variation in size, shape, location, and
texture, there has been a significant need to improve the overall performance of CAD systems and reduce
false positive and negative cases. Consequently, deep learning methodology has been broadly suggested in
biomedical applications and particularly in CAD systems for mammography [49, 50, 51].
In the last two decades, deep learning has shown a growing success in many computers vision tasks
and has proven a capability to overcome complex problems in the medical imaging domain. As a result,
several works have been suggested and applied particularly in mammography, such as for tumors detection
[52, 53], breast lesions segmentation [54, 55], and classification [56, 57].

D. Dissertation organization
The dissertation consists of five main chapters as detailed in the following paragraph:
•

Chapter I presents the scope of the research, and it introduces the motivations taken from applying
medical imaging for breast cancer. It also presents the mammography process and the role of AI in
CAD systems.

•

Chapter II surveys the related works and the state-of-the-art methodologies of computer vision for
CAD applications. It also reveals the limitations and challenges of AI techniques and deep learning
technology for breast cancer diagnosis and highlights the potential solutions for improving the CAD
system performance.
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•

Chapter III focuses on the proposed methods and techniques presented towards an integrated
framework for a CAD system. It details the novel implementations and deep learning architectures
that were proposed for each step defining the entire CAD system for breast cancer diagnosis.

•

Chapter IV details the used mammography datasets and the setting and metrics employed for the
experimental evaluation. Before presenting the general discussion and the comparative results, it
illustrates a testing and deployment section for showcase of the integrated CAD system.

•

Chapter V summarizes the entire work and the proposed methodologies and lays out ten future
works.
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CHAPTER II
LITTERATURE REVIEW MODELS AND METHODS FOR BREAST
CANCER DIAGNOSIS

The present chapter highlights the recent success of several research studies on developing
automated solutions using cutting-edge technology for many medical applications and particularly breast
cancer. Computer vision and AI technology have been merged to produce feasible Computer-aided diagnosis
(CAD) systems to assist doctors during the diagnosis task. As a medical imaging application, an automated
CAD system could be beneficial to save the time on the screening procedure and provide a second reading
that helps reveal any hidden pattern and indication of cancer that could be overlooked. The CAD system
could also contribute to lowering the mortality rate and decreasing the false positive and negative diagnosis.
All the surveyed works in this chapter are based on image analysis and processing methods, pattern
recognition techniques, and machine learning and deep learning technologies. The chapter is organized
according to the main steps that form the integrated framework of a CAD system: tumor detection and
identification, tumor segmentation and background masking, and tumor classification and diagnosis that
presents the final decision. The tasks were conducted in the order we mentioned so that the segmentation step
was applied on the detected region of interest (ROI) of tumors, and similarly the classification and diagnosis
step was applied on the detected and segmented ROI of tumors.
In this chapter, the state-of-the-art methods and architecture models are presented with their applications and
performance results that will be later compared to our proposed methodologies.

A. Introduction
Breast cancer is the most common type of cancer that is leading to death among women, where
43,250 death cases were reported in the United States in 2022 and it represents a rate of 15% of estimated
deaths against the other types of cancer. However, the overall death rate decreased by 1% per year from 2013
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to 2020 because of treatment advancements and early diagnosis through screening. The median age of women
to have cancer is 60 but the risk may occur from the age of 30 to 50. Early detection and diagnosis of breast
cancer is the most effective way to treat the disease to postpone its spread to other healthy organs. The process
of screening may reveal small indicators of abnormalities that may lead later to risky factors of cancer. The
most common screening procedure is the digital mammography that takes snapshot images of the breast
composition and visualizes any irregular pattern for breast cancer.
Due to the increasing number of daily screening mammograms, automated machine could benefit
from the huge amount of the stored medical images and develop a CAD system that performs computational
image analysis and advance features extraction to automatically decide toward the location of the abnormal
tumors, their type, pathology, shape, and assessment.
Accordingly, as shown in Figure 10, a completely integrated CAD system would start its first stage,
with the detection and localization of suspicious lesions and distinguishing between their types, i.e., mass,
calcification, architectural distortion, etc. Then, at a second stage, the CAD system should perform a
segmentation of the obtained region of interest (ROI) surrounding the breast lesion to recognize its anatomical
contour and remove its tissue background without losing its shape precision. Finally, diagnostic information
could be extracted regarding the pathology to classify the decided lesion as either malignant or benign and
identify its characteristics such as a tumor grading using Breast Imaging Reporting and Data System (BIRADS) score, or/and a shape categorization. As the automated procedure relies on connected stages, each
output information must be generated precisely to generate a fast and accurate final decision.

FIGURE 10: Integrated framework of CAD system for breast cancer (A mammogram case with a malignant mass lesion,
BI-RADS score of 4 and irregular shape).
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The rest of the chapter details recent works that were proposed for each step of the CAD system
showing recent techniques and models for implementing every task accordingly. Each subsection compares
the performance results for the conducted task and presents their advantages and limitations.

B. Breast Cancer Detection and Identification
Since its discovery in 1913, mammography has been considered an essential key for early detection
and diagnosis of specious lesions. Mammography screening has helped radiologists identify breast cancer
and several studies showed its impact for a significant reduction in mortality rate [58]. With the remarkable
advances in computer vision and artificial intelligence to assist doctors for medical imaging analysis, many
studies showed the effectiveness of CAD systems to automatically detect suspicious lesions from raw
screened mammograms [59]. The introduction of neural network models changed the CAD’s approach and
substituted the use of hand-crafted features extraction with deep learning architectures that are capable of
learning complex features at different scales [60].
With the development of machine learning technology, many applications have given more attention
in adopting deep learning to solve complex problems, particularly in the fields of computer vision, image
recognition, object detection [32, 38, 39] and segmentation [40, 41]. Due to the limitations of hand-crafted
features derived from raw images, many studies have shown that traditional methodologies have tried to
establish highly accurate models. Indeed, traditional CAD systems that were proposed for breast lesions
detection and classification could not overcome the huge variations in lesions size and texture, compared to
deep learning methods [51, 52]. As a result, several CAD systems based on deep learning architectures have
been successfully developed to improve the detection and classification of organ lesions such as liver lesions,
lung nodules, and, in particular, breast lesions [57, 58].
Researchers have demonstrated the feasibility of regional-based models to build an end-to-end
system for detecting and classifying malignant and benign tumors in the INbreast mammograms and achieved
a detection rate of 89.4% [52]. Peng et al. provided an alternative approach in a recent paper. [61] that
introduced an automated mass detection approach. The method integrated the Faster R-CNN model and
multiscale-feature pyramid network and yielded a true positive rate of 0.93 on CBIS-DDSM and 0.95 on
INbreast dataset.
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Accordingly, Al-Antari et al. [62] employed the YOLO model for breast masses detection that
reported a detection accuracy of 98.96%. The output served after that for mass segmentation and recognition
to provide a fully integrated CAD system for digital X-ray mammograms. Another work by Al-Antari et al.
[63] in 2020 improved the results of the breast lesions detection and classification by adopting first the YOLO
model for detection and then compared feedforward CNN, ResNet-50, and InceptionResNet-V2 for
classification. Similarly, Al-masni et al. [49] proposed a CAD system framework that first detected breast
masses using YOLO model with an overall accuracy of 99.7%, and then classified them into malignant and
benign using FC-NNs (Fully Connected Neural Networks) that achieved with an accuracy of 97%.
Deep convolutional neural networks (DCNN) were also suggested for mammographic mass
detection by using transfer-learning strategy from natural images [64]. Ribli et al. presented a paper in 2018
[65] and proposed a CAD system based on Faster R-CNN framework to detect and classify malignant and
benign lesions and obtained an AUC score of 0.95 on INbreast dataset. Another work employed a fully
convolutional network (FCN) with adversarial learning in an unsupervised fashion to align different domains
while conducting mass detection in mammograms [66].
Indeed, the breast tumor detection task is a crucial step that remains a challenge for CAD systems
where many reliable models were used to support the automatic diagnosis. For example, Singh et al. relied
on the Single Shot Detector (SSD) model to localize tumors in mammograms, and then extracted output
boxes to apply segmentation and classification tasks [67]. It yielded a sufficient true positive rate of 0.97 on
the INbreast dataset. Other recent studies proposed using the YOLO model to achieve a better performance
in detecting bounding boxes surrounding breast tumors. For example, Al-masni et al. [68] presented a YOLObased CAD system that achieved an overall accuracy of 85.52% on DDSM dataset.
Moreover, a tumor localization task was conducted in a detection framework for cancer metastasis
using a patch-based classification stage and a heatmap-based post-processing stage [69]. It achieved a score
of 0.7051 and served for whole slide image classification. Breast tumor detection was also addressed in 2016
by Akselrod-Ballin et al. [70] where images were divided into overlapped patches and fed into a cascaded RCNN model to first detect masses and then classify them into malignant or benign. Dhungel et al. presented
research in 2015 [71] and relied on a multi-scale Deep Belief Network (DBN) to first extract all suspicious
regions from entire mammograms and then filter out the best regions using Random Forest (RF). The
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technique achieved a true positive rate of 96%. Akselrod-Ballin et al. presented a paper in 2017 [72] and
developed a three-stage cascade of Faster-RCNN models to detect and classify abnormal regions in
mammograms. The work was evaluated on the INbreast dataset and achieved an overall detection and
classification accuracy of 72% and 77%.
In another work by Li et al. [73], a bilateral mass detection method was introduced using two
networks: a registration network between left and right breasts and a Siamese-Faster-RCNN network to detect
masses from pairs of registered mammograms. They reported results of a true positive rate of 0.88 on the
INbreast dataset and 0.85 on a private dataset. In addition, Hamed et al. [74] presented a YOLOV4-based
CAD system with 2-path detection of masses in full and cropped mammograms and then classified them into
benign and malignant.
Moreover, early detection and diagnosis of breast cancer in mammography using the deep learningbased CAD systems can help prevent development of tumors by marking lesions, and thus it can effectively
decrease death rate [75]. A retrospective study by Watanabe et al. [76] showed a potential area of
improvement for radiologists’ interpretation of screening mammograms for early detection using Artificial
Intelligence. The studied CAD system succeeded to mark 30 (86%) of 35 missed micro-calcifications and 58
(73%) of 80 missed masses. In addition, missed malignant lesions were flagged as early as 70 months Prior
to recall or diagnostic follow-up. In consequence, CAD systems could benefit from the change that occurred
between Prior and Current mammographic exams. A recent work by Timp et al. [77] tried to improve the
characterization of mass lesions by adding information about the tumor behavior over time. The authors
presented a CAD program to detect temporal changes between two consecutive screening images using a
regional registration method to localize lesions detected on the current views and their corresponding on the
Prior views. After that, a Support Vector Machines (SVM) classifier was applied to show the effectiveness
of temporal features. In a different study, Timp et al. [78] attempted to improve detection methods by
including temporal information in the CAD system. A regional registration technique along feature space
was used to map suspicious locations on the Current mammograms with a corresponding location on the
Prior mammograms with 72% accuracy. Accordingly, Loizidou et al. [79] tried to increase the
microcalcification detection accuracy to 99.2% by adding temporal subtraction between mammogram pairs
before applying SVMs classifier. In the same context, a recent study by Loizidou et al. [80] extended their
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previous work of breast micro-classification detection and classification by adding an image registration step
of Prior mammograms before applying temporal subtraction of pairs. In a different work by Zheng et al. [81],
follow-up digital mammography images were integrated together to develop a CAD method for breast cancer
detection. All regional images were detected using the Haar features, local binary pattern, and histogram of
oriented gradient via the AdaBoost approach and then fed into a CNN to filter out the false positive cases.
Most of the reviewed works and their diagnosis results showed how artificial intelligence has
successfully contributed to solve the challenge of breast cancer detection. In fact, practical implementation,
and system evaluation, as well as the tremendous complexity of memory and time, remain unsolved issues.
Most of the works have tackled the problem of detecting only mass tumors in the entire breast and then
classifying them into malignant and benign. Our approach was developed differently to address the task of
detection and identification of at least two types of breast lesions (i.e., mass and calcification). Our
methodology was also expanded by presenting a fusion-models approach that combines predictions of
different models to improve the results.

C. Breast Cancer Segmentation
With the significant advance in computer vision applications, several studies have focused on
developing deep learning methods for the detection and segmentation of breast mass tumors [82, 83, 84].
Convolutional Neural Networks (CNNs) were among the first architectures that attempted to automatically
learn features from raw images to label pixels surrounding objects at different scales and shapes [85].
Regarding medical image segmentation, one of the well-known architectures is the Fully
Convolutional Network (FCN), which introduced the first encoder-decoder network design. In fact, the
encoder part applies convolutional, max-pooling and down-sampling layers and finally fully connected layers
of VGG-16 to end up with low-level features. The decoder part is like the encoder part by using a
deconvolutional and up-sampling layer [86]. The network was introduced by Hai et al. [87] that added
multiscale image information for automated breast tumor segmentation, and it achieved a Dice score of
76.97% and an IoU score of 60.41% on a private dataset. Al-antari et al. introduced the Full resolution
Convolutional Network (FrCN) [62], which is a version of the FCN, to segment the detected breast masses,
and it produced a Dice score of 92.69% and a Jaccard similarity coefficient of 86.37% on INbreast dataset.
Accordingly, Zhu et al. [88] employed a multi-scale FCN model followed by a conditional random field
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(CRF) for mammographic mass segmentation, and they achieved Dice score of 90.97% on the INbreast
dataset and 91.30% on the DDSM-BCRP dataset. Another work proposed by Singh et al. [89] was inspired
by the FCN architecture and developed a conditional Generative Adversarial Network (cGAN) for breast
tumor segmentation. The work achieved a Dice score of 92.11% and an IoU score of 84.55% on the INbreast
dataset and a Dice score of 88.12% and an IoU score of 79.87% on a private dataset.
Medical image segmentation usually presents challenging cases; and consequently, this type of
network suffers from low segmentation accuracy due to the loss of spatial resolution in case of small objects
and irregular shapes. As a result, Ronneberger et al. developed a new model called UNet [90] to overcome
the limitation of FCN models. UNet proposed to integrate the high-level features from the decoder, which
preserve the semantic information, with the low-level features from the encoder, which represent the spatial
information. The fusion was maintained with the skip connections that made the UNet architecture adequate
in several medical applications and particularly in mammography. A work presented by Sathyan et al. [91]
employed the UNet model to segment mass and calcification in whole mammograms and achieved a Dice
score of 67.3% on the CBIS-DDSM dataset. Another work by Soulami et al. [92] relied on an end-to-end
UNet model for the detection, segmentation, and classification of breast masses in one stage, where the
segmentation evaluation showed a Dice score of 90.5% for both DDSM and INbreast datasets.
Many potential scopes of improvement were recently suggested on the UNet architecture to improve
its performance and enhance the quality of the segmentation [93]. Inspired by the residual mechanism,
Abdelhafiz et al. [94] proposed the residual UNet, called RUNet or ResUNet, by adding residual blocks to
the standard convolutional layer in the encoder pathway to add a deeper effect to the network. The work was
applied for mass segmentation and then detected binary maps were fed to a ResNet model for classification
into benign or malignant. Segmentation results yielded a Dice score of 90.5% and a mean IoU score of 89.1%
on the INbreast dataset. Similarly, Ibtehaz et al. [95] developed a novel architecture, called MultiResUNet,
which showed a remarkable gain in performance for biomedical image datasets. The work replaced the
standard blocks of the encoder-decoder by multi-residual blocks and altered the plain skip connection with
residual paths. Accordingly, a Conditional Residual UNet, called CRUNet, was also suggested by Li et al.
[96] to improve the performance of the standard UNet for breast mass segmentation, and it achieved a Dice
score of 92.72% on the INbreast dataset.
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Another variation of the UNet was suggested using the attention mechanism that showed remarkable
success in medical image segmentation [97]. Consequently, Oktay et al. [98] integrated the attention gate
into the standard UNet to propose a new Attention UNet, called AUNet. It improved the prediction
performance across CT pancreas segmentation and yielded a Dice score of 83.1%. Similarly, Li et al. [99]
developed an Attention dense UNet for breast mass segmentation that achieved better results than UNet,
AUNet and DenseNet with a Dice score of 82.24% on the DDSM database. In another work suggested by
Sun et al. [100], a novel attention-guided dense-upsampling network was developed for breast mass
segmentation in whole mammograms. The architecture achieved a Dice score of 81.8% on the CBIS-DDSM
dataset and 79.1% on the INbreast dataset. Similarly, Ravitha Rajalakshmi et al. [101] introduced a deeply
supervised U-Net model (DS U-Net) associated with dense CRFs to segment suspicious regions on
mammograms. The model was tested and gave a Dice score of 82.9% and 79% respectively on CBIS-DDSM
and INbreast datasets.
Aligned with the improvement made in encoder-decoder architecture to deal with the limitations
encountered in medical images segmentation, the Atrous Spatial Pyramid Pooling (ASPP) module was
successfully integrated in many networks [102]. It showed effectiveness in breast mass segmentation in a
work presented by Wang et al. [103] that achieved a Dice score of 91.10% and 91.69%, respectively on the
INbreast and DDSM-BCRP datasets.
The depth of the UNet architecture was exposed through studying it, as well as the limited design
of skip connections. Therefore, a novel architecture, named UNet++, was introduced by Zhou et al. [104] to
alleviate the network depth and redesign the standard skip connections. The research was tested on six
medical image datasets with diverse modalities, and it showed similar results for semantic and instance
segmentation tasks. A similar variation model, called U-Net+, was employed by Tsochatzidis et al. [105] to
segment ROI mass before integrating it with the classification stage by a CNN model. On the CBIS-DDSM
and DDSM-400 datasets, the segmentation performance had a Dice score of 0.722 and 0.738, and a Jaccard
index of 0.565 and 0.585, respectively.
Furthermore, to cope with difficult medical imagery, Jha et al. [106] presented a DoubleUNets
architecture that uses two encoders and two decoders in sequence and an ASPP module. On four medical
segmentation datasets, the network outperformed both the baselines and UNet Das et al. [107] proposed a
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Contour-Aware Residual W-Net, termed WRC-Net, which consists of double UNets. The first UNet was
designed to predict objects boundaries and the second UNet generated the segmentation map. The work was
evaluated on stained cell images, and it outperformed the state-of-the-art nuclei segmentation techniques.
Additionally, a new variation of the UNet was presented by Tran et al. [108], named TMD-UNet,
that modified the interconnection of the network node, replaced the standard convolutions with dilated
convolutions layers, and developed new dense skip connections. For liver, polyp, skin lesion, spleen, nuclei,
and left atrium segmentation, the network outperformed popular models.

D. Image-to-image Translation
With the significant attention given on improving the performance of neural networks algorithms,
many studies have focused on enhancing the quality of medical images that are acquired using multiple
imaging modalities. Lately, image-to-image translation has been employed to solve many computer vision
applications in medical imaging, such as image synthesis and reconstruction.
In fact, deep learning models require a large amount of annotated data to achieve a robust behavior.
However, it is often difficult for medical applications to collect enough instances. Therefore, synthetic data
was recently adopted to increase the size of dataset, within either the same image modality, or using crossmodality translation. In a work presented by Senaras et al. [109], a conditional Generative Adversarial
Network was applied to generate synthetic images that were indistinguishable from real images of a breast
cancer database. Accordingly, Alyafi et al. [110] employed Deep Convolutional GAN (DCGAN) to generate
synthetic mammograms with mass lesions to enhance the classification performance in imbalanced datasets.
Another recent technique that was widely used for unpaired image-to-image translation is the cycleconsistent Generative Adversarial Network (CycleGAN), and it was developed by Zhu et al. [111]. The
technique learns two mappings by transforming images between two different domains using two GANS and
maintains their reconstruction by a cycle-consistency loss and hence the name. Becker et al. [112] presented
CycleGAN model to artificially inject or remove suspicious features and thus increase the size of the BCDR
and INbreast datasets. Moreover, a cross-modality synthesis approach was introduced by Cai et al. [113]. It
was motivated by CycleGAN between CT and MRI, and it was tested on 2D/3D images for segmentation.
Another similar work by Hiasa et al. [114] extended the CycleGAN approach by adding gradient
consistency loss and aimed for MRI-to-CT synthesis. The work yielded a better segmentation precision on
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musculoskeletal images. Upon such an idea, Huo et al. [115] proposed an end-to-end synthesis and
segmentation network (EssNet) to conduct the unpaired MRI to CT images synthesis and CT splenomegaly
segmentation without using manually annotated CT. It achieved a higher Dice score of 91.88% than the stateof-the-art performance.
A similar architecture called Pix2Pix was also suggested for image-to-image translation but using
paired datasets [116]. A recent application by Shen et al. [117] employed the Pix2Pix network for image-tomask segmentation in mammography. Pix2pix was also employed by Liao et al. [118] to artificially remove
artifacts in CT scans and the method showed improvement for clinical image reconstruction.

E. Breast Cancer Pathology & Diagnosis Classification
Computer-aided diagnosis (CAD) systems have recently used advanced computer vision techniques,
artificial intelligence, and machine learning approaches to automatically extract information from digital
medical images to assist experts in their final diagnostic decisions. Several research studies have attempted
to suggest methods to assist doctors in their diagnosis and have focused on improving results of breast mass
classification in digital mammography. In this context, Dhahri et al. [119] used a Tabu search to select the
most significant features and then fed them into a K-Nearest Neighbors (KNN) algorithm to classify breast
lesions into malignant or benign. This methodology required four iterative stages and achieved an accuracy
of 98.24% on the WDBC dataset.
Since their development, many studies have given more attention to incorporating deep learning
methods in CAD systems as they showed better efficiency than traditional CAD systems that require
extensive features extraction. For instance, an end-to-end approach was developed by Shen et al. [38] to
classify whole-digital mammograms into cancer or normal. The work demonstrated a new CNN structure
using VGG network and the residual network (ResNet) and accomplished an AUC of 0.91 on the CBISDDSM dataset and an AUC of 0.98 on the INbreast dataset. Another end-to-end model, called DiaGRAM,
was built by Shams et al. [120] that combined CNN and Generative Adversarial Networks (GAN). The work
was conducted to classify mammograms as benign or cancerous. Experiments showed an accuracy of 89%
on the DDSM dataset and 93.5% on the INbreast dataset. An improved deep learning method, called the new
DenseNet-II model, was invented in a work by Li et al. [121] for classification of benign and malignant
mammography images. The model was analyzed and applied on a private collection of mammography images
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and reached an accuracy of 94.55%. Accordingly, a novel model for mass classification was proposed by
Zhang et al. [122] that fused texton features from local binary pattern extraction, with deep CNN features.
The model was tested on a CBIS-DDSM dataset and achieved an accuracy of 94.30%. In another work by
Muramatsu et al. [123], a CNN model’s performance was improved by adding synthetic data generated from
lung nodules in computed tomography (CT) using cycle generative adversarial networks. The classification
performance was tested on a DDSM dataset and achieved an accuracy of 81.4%. Recently, Chakravarthy et
al. [124] proposed a novel method that coordinates the deep learning with an extreme learning machine
(ELM) optimized by employing a basic crow-search algorithm for classifying ROI images with abnormality
into malignant or benign. The proposed work achieved a maximum overall accuracy of 97.19% on DDSM,
98.13% on the Mammographic Image Analysis Society (MIAS) dataset and 98.26% on INbreast datasets. In
a recent work by Khan et al. [125], multi-view feature fusion (MVFF) based-CAD system was implemented
to increase the performance of CNN by combining information of four views of mammograms to classify
them first into abnormal or normal, then into mass or calcification, and finally into malignant or benign. The
final pathology classification achieved an AUC of 0.84 on the CBIS-DDSM and mini-MIAS databases.
Moreover, Kumar et al. [126] suggested a classification framework for breast density using an
ensemble of 4-class neural network classifiers. The work showed an overall classification accuracy of 90.8%
on the DDSM dataset. Besides ensemble learning mythology, transfer learning was also adapted with deep
learning techniques to develop an approach for differentiation between benign and malignant breast cancer
cases in X-ray images [127]. Hence, in a work by Alkhaleefah et al. [128], double-shot transfer learning
(DSTL) was used by fine-tuning various pre-trained networks once on an ImageNet dataset, and another time
on a larger dataset like the target dataset. The method was trained on CBIS-DDSM and showed a better
performance than single-shot transfer learning with an average AUC of 0.99 on the MIAS dataset and 0.94%
on the BCDR dataset. Similarly, Falconí et al. [129] used transfer learning on a NasNet Mobile model and
fine tune on VGG models to classify mammogram images according to the BI-RADS scale. The work
achieved an accuracy of 90.9% on the INbreast dataset. Recently, a work by Medeiro et al [130] combined
DenseNet201 and multi-perceptron layer (MLP) models to classify the pathology within BI-RADS levels 3
and 4 for malignancy of breast masses. The model achieved an accuracy of 63% surpassing the performance
of a human expert by 9.0%.
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To accomplish an efficient mass classification and diagnosis procedure, researchers have shown that
capturing texture and morphological characteristics could help doctors understand the nature of the breast
tumor and assess its malignancy scale. For instance, research by Bi et al. [131] showed that the probability
of malignancy is highly correlated with the shape and morphology of a breast lesion. Therefore, several works
have incorporated the segmentation stage to provide a complete, significant diagnosis [132]. In a previous
work by Tsochatzidis et al. [105] modified convolutional layers of a CNN to integrate both input images and
their corresponding segmentation maps to improve the diagnosis of breast cancer in mammograms. The
method was applied on DDSM-400 and CBIS-DDSM datasets and achieved a diagnosis performance AUC
of 0.89 and 0.86. Similarly, a dual convolutional neural network was suggested by Li et al. [133], which
computed the mass segmentation and simultaneously predicted the diagnosis results. The model contributed
an improvement to the mass segmentation and cancer classification problem at the same time and achieved
an AUC of 0.85 on the DDSM dataset and 0.93 and the INbreast dataset.
Recently, most of the developed CAD systems have automated the breast cancer diagnosis procedure that
gets an entire mammogram image and returns a final diagnosis. Thus, many studies have integrated the first
stage of identifying the suspicious region of breast lesions and based on its automated output, performed the
segmentation and classification tasks. For instance, Sarkar et al. [134] proposed an automated CAD system
that detects suspicious regions of potential lesions using a deep hierarchical prediction network and then
classifies them into mass or non-mass, and finally into malignant or benign using a CNN structure. The work
was tested and achieved an accuracy of 98.05% on the DDSM dataset and 98.14% on the INbreast dataset.
Another fully automated system by Dhungel et al. [135] for breast mass classification integrated mass
detection and segmentation in a complete CAD system. The methodology used a multi-scale deep belief
network (m-DBN) classifier followed by a cascade of CNNs and random forest classifiers for false positive
reduction for mass detection, a conditional random field (CRF) for mass segmentation, and a multi-view deep
residual neural network (mResNet) for mass classification. The proposed work achieved an AUC of 0.8 on
the INbreast dataset. Another recent work by Singh et al. [136] presented automatic workflow that detects
breast tumor regions from mammograms using the Single Shot Detector (SSD), and then outlines its
segmented mask using conditional Generative Adversarial Network (cGAN) that was finally used for shape
classification using a CNN. The framework achieved an overall accuracy of 80% for the shape classification.
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Similarly, Al-Antari et al. [62] proposed a fully integrated CAD system for digital mammograms via deep
learning techniques. It started with a mass detection using the You-Only Look Once (YOLO) architecture
model, then performed a mass segmentation on the detected regions using Full resolution convolutional
network (FrCN), and finally classified the detected and segmented masses into benign or malignant using a
CNN model. The entire framework had an overall classification accuracy of 95.64% on the INbreast dataset.
The mass classification step was differently solved in a recent work of Al-Antari et al. [137] that separately
adopted three conventional deep learning models including regular feedforward CNN, ResNet-50, and
InceptionResNet-V2. The work achieved a maximum accuracy of 95.32% on the INbreast dataset.

F. Conclusion and discussion
The reviewed state-of-the-art works highlighted models that have proved outstanding success on
medical images. These models were evolved from a simple Convolutional Neural Networks (CNNs) model
to present other variations such as R-CNNs, Fast CNNs and Faster R-CNNs Models. These popular models
have overcome many limitations of deep learning such as computational time, redundancy, overfitting, and
parameter size. However, most of these models take a long time to train and implement and require a lot of
computing resources. Therefore, another variation called You-Only-Look-Once (YOLO), which is
characterized with a low-memory dependence, has been recently recognized as a fast object detection model
and suitable for CAD systems.
In this dissertation, we propose an end-to-end system that is based on the YOLO-based model to
simultaneously detect and identify breast lesions into two most common abnormalities, Mass tumors or
Calcification. Our approach contributes with a new feature, which is an end-to-end system that can recognize
both types of suspicious lesions whether only one type exists in an image, or both simultaneously appear in
the same image. As the choice of YOLO model was stated earlier, the proposed implementation will also
serve as a basic step for the integrated framework for CAD system to present a complete breast cancer
diagnosis.
The performance of the first step was demonstrated on different mammography datasets using deep
learning methodologies (i.e., data augmentation, early stopping, hyperparameters tuning and transfer
learning). An additional contribution was presented in this work to boost the lesions detection and
identification performance as follows. Because the performance varies according to the input data of the
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model, single evaluation results were first reported over the variations of images, then different fusion models
were developed to increase the final detection accuracy rate and join models with different configurations.
The suggested methodology will ensure the best-detected bounding boxes and remove the bad predictions
that can mislead the future diagnostic tasks. Experiments were conducted on two most widely used datasets:
CBIS-DDSM and INbreast, and on an independent private dataset. The outcome of this work will justify the
performance of the YOLO-based model for deep learning lesion detection and identification on
mammography. It will also serve as a comparison study of YOLO-based model performance on various
mammograms.
Inspired by the reviewed works and their diagnosis results, we expanded the study on another
mammography dataset that includes Current and Prior screening views for conducting an early detection task
retrospectively. We first apply the YOLO-based fusion models on the most recent screening mammograms
to detect and identify three types of breast lesions (i.e., Mass, Calcification, Architectural distortion). Second,
we suggest replicating the early-screened mammograms with cancer diagnosis and maintaining prior shape
and appearance into synthetic Prior mammograms that resemble the Current mammograms. The model that
was trained on the Current views will be inferred retrospectively on the new Prior views to predict the
suspicious findings that were missed at initial screening.
We evaluated two state-of-the-art techniques for image-to-image translation, CycleGAN and Pix2Pix and
compared their performance on predicting location and type of lesions on Prior mammograms at early
screening.
Motivated by the surveyed works on breast tumors segmentation, we suggest a novel architecture
that incorporates all the recent approaches that were suggested to improve the breast masses segmentation
task. We elaborate a new segmentation architecture that is based on the standard UNet and its two variations.
Our approach also aims to evoke the CycleGAN method for a synthetic data augmentation between different
mammography datasets to make benefit from the similar domains.
The second step of the CAD system was applied only on the detected Mass lesions after filtering
their type and location from the mammograms. Other abnormalities were discarded for the lack of their
ground truth diagnostic information.
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Inspired by the continuous success of the CNN model and its variations for breast mass
classification, and the high performance of the ensemble model technique on machine learning, we propose
a stacked ensemble of residual network (ResNet) models to classify and diagnose previously detected and
segmented mass lesions. The proposed model uses three different architectures of the ResNet model,
ResNet50V2, ResNet101V2, and ResNet152V2 that are transferred and fine-tuned on the public and private
mammography datasets. The models’ layers are stacked together and reconfigured into a new entire model
for an overall classification and diagnosis of 1) the pathology as malignant or benign; 2) the BI-RADS
category as assessment score from 2 to 6; and 3) the shape as round, oval, lobulated, or irregular. All surveyed
works are grouped and categorized into the Table 2.
Table 2: Related works

Reference

Year

Methods

Dataset

1) Breast Lesions Detection & Identification
Kozegar et al. [31]

2013

Adaptive threshold machine learning

INbreast

Agarwal et al. [32]

2019

CNN patch classifier and mass probability

CBIS-DDSM

map (MPM)

INbreast

Al-masni et al. [49]

2018

YOLO

DDSM

Aly, G. et al. [52]

2020

YOLO

INbreast

Peng et al. [61]

2020

Faster R-CNN

Al-Antari et al. [62]

2018

YOLO

INbreast

Al-Antari et al. [63]

2020

YOLO

INbreast

Singh et al. [89]

2020

Single Shot Detector (SSD)

INbreast

Ribli et al. [65]

2018

Faster R-CNN + FCN

INbreast

Al-masni et al. [68]

2017

YOLO

DDSM

Akselrod-Ballin et al. [70]

2016

cascaded R-CNN

INbreast

Dhungel et al. [71]

2015

Deep Belief Network (DBN)

Akselrod-Ballin et al. [72]

2017

three-stage cascade of Faster-RCNN models

INbreast

Li et al. [73]

2020

Siamese-Faster-RCNN

INbreast

Hamed et al. [74]

2021

YOLOV4

INbreast

Watanabe et al. [76]

2019

cmAssist – Custom deep learning networks

Private

Timp et al. [77]

2007

temporal change features + SVM

Private

Timp et al. [78]

2006

regional registration technique

Private

Loizidou et al. [79]

2019

Temporal subtraction

Custom
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CBIS-DDSM
INbreast

DDSM-BCRP
INbreast

Loizidou et al. [80]

2020

Image registration

Custom

Detection: 3 cascading detectors (Haar, LBP,
Zheng et al [81]

2018

and HOG)

UCHCDM

Classification: VGG-19
Dhungel et al. [167]

2017

Cascade Deep Learning and Random Forest

INbreast

Dhungel et al. [83]

2015

Deep structured output learning + refinement

INbreast

Dhungel et al. [135]

2017

conditional GAN (cGAN)

INbreast

Isfahani et al. [186]

2021

Growth regional method

MIAS

Silalahi et al. [187]

2021

CNN (VGG + ResNet)

MIAS

Yassir et al. [188]

2022

YOLOv5 + Mask RCNN

INbreast

2) Biomedical Lesions Segmentation
Al-Antari et al. [62]

2018

AUNet

INbreast

Hai et al. [87]

2019

Fully connected VGG-16

Private

Zhu et al. [88]

2018

Full resolution convolutional network (Front)

INbreast

Singh et al. [89]

2020

CNN + CRF

INbreast

Ronneberger et al. [90]

2015

UNet

Biomedical Images

Sathyan et al. [91]

2020

UNet

CBIS-DDSM

Soulami et al. [92]

2021

UNet

Abdelhafiz et al. [94]

2019

UNet-128

INbreast

Ibtehaz et al. [95]

2020

MultiResUNet

Biomedical Images

Li et al. [96]

2018

Conditional Residual Unet

INbreast

Oktay et al. [98]

2019

Attention dense Unet

DDSM

Sun et al. [101]

2020

ASPP-FC-DenseNet

private

R-Unet

INbreast

ResNet34 + ASPP

INbreast

CRUNet

INbreast

Ravitha Rajalakshmi et al.
[101]

2020

INbreast
DDSM

Wang et al. [103]

2019

Multi-scale FCN-CRF

INbreast

Zhou et al. [104]

2019

Unet++

Biomedical Images

Tsochatzidis et al. [105]

2021

Unet+

CBIS-DDSM

Jha et al. [106]

2020

DoubleUNets

Biomedical Images

Das et al [107]

2019

Contour-Aware Residual W-Net (WRC-Net)

Biomedical Images

Tran et al. [108]

2021

TMD-Unet

Biomedical Images

Irfan et al. [182]

2021

Di-CNN + morphological erosion operation.

Ultrasonic

Li et al. [183]

2022

Sharma et al. [184]

2022

Class activation mapping and deep level set
(CAM-DLS)
Xception model + SVM classifier
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Breast Ultrasound
Histology Images

3) Breast Cancer Diagnosis & Classification
CBIS-DDSM

Shen et al. [38]

2017

CNN + VGG

Singh et al. [89]

2020

CNN

DDSM

Al-Antari et al. [62]

2018

Ensemble of AlexNet-based CNN

INbreast

Shams et al. [120]

2018

CNN + GAN

Li et al. [121]

2019

DenseNet-II

Private

Zhang et al. [122]

2020

Local binary patter and Deep CNN features

CBIS-DDSM

Chakravarthy et al. [124]

2020

Khan et al. [125]

2019

Alkhaleefah et al. [128]

2020

Falconí et al. [127]

2019

MobileNet and NasNet + fine tuning

CBIS-DDSM

Medeiro et al [130]

2020

DenseNet201 + MLP

CBIS-DDSM

Li et al. [133]

2020

Tsochatzidis et al. [105]

2021

Dhungel et al. [135]

2017

Falconí et al. [129]

2020

NasNet + fine tuning on VGG16 and VGG19

INbreast

Falconí et al. [178]

2020

VGG16 + fine tuning

CBIS-DDSM

Improved Crow-Search Optimized Extreme
Learning Machine (ICS-ELM) algorithm
multi-view feature fusion (MVFF)
AlexNet, VGG, GoogLeNet, ResNet
+ fine tuning

DualCoreNet: Texture
and shape features fusion
CNN
multi-view deep residual neural network
(mResNet)

INbreast

DDSM
INbreast

INbreast
CBIS-DDSM
CBIS-DDSM

INbreast
CBIS-DDSM
INbreast

Fusion of CNN-activated feature vectors and
Irfan et al. [182]

2021

DenseNet201-activated

Ultrasonic

feature vectors combined with SVM
Ayana et al. [184]

2022

Zhou et al. [189]

2022

esNet50-Adagrad-based multistage transfer
learning (MTL)
Resolution adaptive network (RANet)

29

Ultrasonic
Histopathological

CHAPTER III
PROPOSED METHODOLOGY

A. Introduction
This chapter presents technical details about the architecture models and approaches that were
adapted to develop a complete CAD system for breast cancer diagnosis. The models are based on deep
learning technology and motivated by the latest cutting-edge computer vision techniques. Each step of the
integrated CAD system is solved using a novel architecture model that was trained on mammograms to extra
deep features for the detection of breast abnormalities and localize them in the entire mammogram; the
segmentation of the breast tumors and masking their background; and the classification of the tumors for a
final diagnostic decision. The proposed detection and identification step was conducted with a fusion-models
approach that is based on the YOLO architecture model. The same idea was tested on an external dataset that
acquires current mammograms and their corresponding prior screening views. The model was inferred on
synthetic prior images that were generated using an image-to-image translation technique Pix2Pix and
retrospective analysis was used to evaluate the early detection and classification of abnormalities in prior
mammograms. Next, the segmentation step was solved with a novel segmentation architecture model, called
Connected-UNets. The performance was enhanced using additional synthetic images using image-to-image
translation methods. Finally, the classification step was developed using a stacked ensemble of Residual
Neural Networks (ResNet) models.
The following sections detail each methodology and approach that was proposed in this work.

B. YOLO-based fusion model for Abnormalities Detection and Identification
1. YOLO-Based Model
Object detection refers to a regression problem that maps the right coordinates of image pixels to a
bounding box that surrounds a specific object. After being fed into a CNN that builds a convolutional feature
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map, popular regional-based neural networks models predict multiple bounding boxes and use regions to
locate objects within images. This approach applies a selective search that extracts most adequate regions
from images and then predicts the offset values for the final bounding boxes. Typically, this technique is
experimentally slow and memory consuming, therefore YOLO (You-Only-Look-Once) deep learning
network was proposed where a single CNN predicts at the same time bounding boxes allocation and their
class label probabilities from entire images. The fact that YOLO does not involve extracting features from
sliding windows leads to its low computing cost. In fact, it only uses features from the entire image to directly
detect each bounding box and predict its class label probability.
YOLO architecture, as explained in Figure 11, is simply based on the fully convolutional neural
network (FCNN) design. Particularly, it splits each entire image into m x m grids and for each grid, B
bounding boxes are returned with a confidence score and C class probabilities.

FIGURE 11: Proposed YOLO-based architecture

Confidence score is computed by multiplying the probability of an existing class object with the intersection
over the union (IoU) score as detailed in Eq. (1).
Confidence = Prob (object) × IoU score

(1)

In addition, the detected object is classified as mass or calcification according to its class probability and its
confidence score for that specific class label as explained below in Eq. (2).
C class probability = Prob (Class object) × IoU score
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(2)

In this dissertation, at the time our recent work was published, we adopted YOLO-V3, which is the
third improved version of YOLO networks, to detect more different scaled objects, and it uses multi-scale
features extraction and detection. As shown in Figure 11, the architecture first employs an extraction step
that is based on the DarkNet backbone framework [138]. It was inspired by the ResNet architecture and
VGG-16, and it presents a new design of 53 layers, as illustrated in the lowest block in Figure 11. The model
uses skip connections to prevent gradients from diminishing and vanishing while propagating through deep
layers. After that, the extracted features at different scales are fed into the detection part that presents three
fully connected layers. After that, it applies the concept of anchor boxes that is borrowed from Faster-RCNNs
model. In fact, the prior boxes were pre-determined by training a K-means algorithm on the entire images.
After that, the output matrixes of multi-scale features were defined as grid cells with anchor boxes. This helps
to determine the IoU percentage between the defined ground-truth and anchor boxes. It also ensures selecting
the boxes with the best scores compared to a certain threshold. At the end, four offset values of bounding
boxes against each anchor box were predicted with a confidence score and a class label probability. Hence,
the detection considered correct bounding boxes that had both scores exceeding a certain threshold [139].

2. Fusion Models Approach
According to the generalized YOLO-based model we presented earlier in Figure 11, the bounding
boxes that surround suspicious breast lesions are detected with certain confidence scores as explained in the
previous subsection. This score is affected by model settings, input data provided to the model, and YOLO's
internal classification process to calculate the class label probability score (i.e., Mass or Calcification). Based
on this hypothesis, evaluation of such a model can be expanded to improve the final predictions results.
We proposed in this dissertation that the best predicted bounding boxes be chosen first among all
augmented images (i.e., rotated, morphed, translated, etc.) based on their IoU score. The idea helped to
determine the best representative mammograms to correctly localize and classify breast lesions. Second, we
suggested joining different predictions of the model’s implementation to lower the error rate and combine
performance of differently configured models. These models were trained and set differently, resulting in a
fusion-based model devoted to achieving the best results.
In fact, we note that Model1, referred to as M1, is trained and configured differently for one class
targeting either Mass or Calcification. Therefore, the two developed models from M1 are now referenced as
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M1(Mass) for Mass class and M1(Calcification) for Calcification class. Model2, referred to as M2, is
configured for multi-class training and identification and used for fusion to improve the performance of
single-class models. The model M2 will now be identified as M2(Mass and Calcification) since it targets
multiple classes.
After developing and testing each model Mi, our proposed fusion approach is to create a fusion
model for Mass class using M1(Mass) and for Calcification class using M1(Calcification), while benefiting
from the M2(Mass and Calcification) to improve the performance of the M1 models.
We first report the Mass predictions1 using M1(Mass) that have IoU score more than threshold1.
Next, we select only images with Mass lesions and report their predictions using M2(Mass and Calcification)
and another threshold2. After that, we filter out predicted images that are not within the Mass predictions1
and save them as Mass predictions 2. We finally combine the two predictions into final Mass predictions as
shown in Figure 12. We repeat the same logic for Calcification predictions according to the flow in Figure
12. In all our fusion models, we used a threshold1 to be 0.5 and threshold2 to be 0.35 that yielded satisfying
results.

FIGURE 12: Flow chart of the fusion models’ approach for the final prediction (examples of Input mammography images
that includes single lesions and different lesions cases from the CBIS-DDSM dataset)

C. Early Detection and Classification of Abnormalities in Prior Mammograms
As the previous work detailed, we employed a YOLO-based model in a different evaluation fashion.
The basic model was initially trained using different configurations (i.e., target class labels). Then, each
experiment was evaluated by selecting the best predicted bounding boxes within all augmented images (i.e.,
original, and rotated images) having the highest confidence score. The technique proved an effective way to
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determine the best representative images to precisely detect and classify breast lesions in each mammogram.
After that, as shown in Figure 13, the idea of YOLO-based fusion models was implemented to improve the
final prediction results. Different predictions were joined to lower the final error rate and to combine models
that were differently configured. We used the same notation by referring Model1 to the YOLO-based model
that was trained and configured for one class either Mass, Calcification, or Architectural Distortion.
Therefore, Model2 refers to the YOLO-based model that was configured for multiple classes training (i.e.,
all three classes together). Finally, the Fusion Model refers to the combined evaluation of Model1 and Model2
that was used to improve the overall detection performance. The final model should select predictions that
were not within the single class predictions according to a threshold of 0.5, which showed satisfying results.
All models were developed and tested on the Current mammograms from the most recent screening, with
either Mass, Calcification or Architectural Distortion lesions. Different from our previous work, we added a
class label, ‘Normal’ for the current mammograms that were not diagnosed with abnormal findings during
the follow-up screening. Our trained YOLO-based model on abnormal mammograms was applied on Normal
mammograms to ensure that no bounding boxes were predicted, and consequently, classify the mammograms
as Normal.

FIGURE 13: YOLO-based Fusion model - Example of mammogram with a Mass lesion

In this task, we first apply and evaluate the YOLO technique on the Current mammograms to detect
different breast lesions and classify them into Mass, Calcification, or Architectural Distortion, and the rest to
Normal. Second, we consider two image-to-image techniques, Pix2Pix and CycleGAN, to learn mapping
between Current mammograms and their corresponding Prior mammograms. As shown in Figure 14, new
synthetic Prior mammograms are generated to overcome the misalignment between the screenings due to
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temporal and texture changes. Next, the trained models on the first step are used to predict the location and
type of breast lesions on the translated Prior mammograms. Predicting the bounding boxes for suspicious
lesions of “future cancers” in Prior mammograms is challenging. Therefore, we integrate all diagnostic
information into one framework that explores possible evidence of invisible patterns for indicating the risk
of “future cancer”. Inference models are directly applied on translated Prior mammograms and evaluation
was carried out using true bounding boxes’ positions and class labels of their corresponding Current
mammograms.

FIGURE 14: Framework for early detection and classification on Prior mammograms (Example of Prior mammogram
with normal diagnosis and Current mammogram with Mass lesions (red bounding boxes))

D. Novel Connected-UNets architecture model for Breast Mass Segmentation
UNet is considered as a state-of-the-art model for medical image segmentation. Inspired by the Fully
Convolutional Network (FCN), it is based on the encoder-decoder structure by removing the fully connected
layers. The network has a symmetric architecture with a u-shape, as the name suggests. It has two paths: one
for down-sampling and one for up-sampling. The remarkable contribution of UNet architecture was the
introduction of the skip connections path that added an advantage to the standard encoder-decoder
architecture. This helps recover the spatial information that gets lost during the down-sampling path due to
the pooling operations.
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Inspired by the efficiency of the skip connections, we propose a new architecture, called ConnectedUNets, which connects two UNets using additional skip connections. Figure 15 shows an overview of the
proposed architecture, where it consists of two standard encoder and decoder blocks and two Atrous Spatial
Pyramid Pooling (ASPP) blocks for the transition between the two pathways. We suggest connecting the first
decoder and the second encoder blocks with new modified skip connections to reconstruct the decoded
information in the first UNet before being encoded again in the second UNet. Each encoder block includes
two convolution units, which consist of 3 x 3 convolutions followed by an activation ReLU (Rectified Linear
Unit) and a batch normalization (BN) layer. Before sending the information to the next encoder, each encoder
block's output is subjected to a maximum pooling function. Each decoder block consists of a 2 x 2 transposed
convolution unit (i.e., deconvolution layer) that is concatenated with the previous encoder output, and then
the result is fed into two convolution blocks, which consist of 3 x 3 convolutions followed by an activation
ReLU and a BN layer.

FIGURE 15: The proposed Connect-UNets architecture

An ASPP block is used to transition between the down-sample and up-sample routes. As the name
indicates, this technique uses “Atrous” (which means “holes” in French) convolution to allow having a larger
receptive field in the transition path without losing resolution. As shown in Figure 16, it is composed of four
dilated 3 x 3 convolutions layers with dilation rate r = {0, 6, 12, 18} and followed by BN layers. The four
sup-blocks are next added to create a multi-scaled features block that is finally fed into a 1 x 1 convolutions
layer.
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FIGURE 16: The Atrous Spatial Pyramid Pooling (ASPP) block

After going through the first UNet, a second UNet is attached through new skip connections that
use information from the first up-sampling pathway. First, the result of the last decoder block is concatenated
with the same result after being fed into a 3 x 3 convolutions layer followed by an activation ReLU and a BN
layer. This is used as the input for the second UNet's initial encoder block. After that, the output of the
maximum pooling operations of each three encoder blocks are fed into 3 x 3 convolutions layers and then
concatenated with the output of the last previous decoder block. The result is next down sampled to the next
encoder block. The second UNet's last encoder block is transferred to the ASPP block, and the rest is the
same as the first UNet. Finally, the last output is given to a 1 x 1 convolutions layer that is followed by a
sigmoid activation layer to generate the predicted mask.
In addition to the proposed design, which is based on the standard UNet, we present the AUNet
model, which includes an attention block throughout the up-sampling process. This combines the attention
technique with the encoder and decoder blocks' skip connections. Indeed, the additional attention block
should allow the network to weight the low-level features (i.e., information that has been down-sampled)
before being concatenated with the high-level features (i.e., up-sampled information) during the skip
connections. Thus, a new Connected-AUNets architecture is introduced as illustrated in Figure 17.
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FIGURE 17: The proposed Connect-AUNets architecture

In fact, the attention block, as shown in Figure 18, consists of a 2 x 2 transposed convolutions layer
with strides equal to (2,2) and takes low-level features as input. Next, the output is concatenated with the
high-level features and the result is fed into a ReLU activation layer followed by a 2 x 2 transposed
convolutions layer with strides equal to (1,1) and a sigmoid activation layer. This generates the attention map
that is next multiplied by the skip connect input to produce the final output of the attention block, which
serves as a new input of the decoder block.

FIGURE 18: The attention block

We replace the usual convolution blocks with residual convolution blocks, motivated by the
improvement made to the UNet architecture to make it strong enough for segmenting medical images with
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diverse sizes. Therefore, the proposed architecture has become the Residual UNet (ResUNet), and
consequently we proposed a new Connected-ResUNets architecture as detailed in Figure 19.

FIGURE 19: The proposed Connect-ResUNets architecture

Consequently, adding the residual convolution blocks should enhance the UNet architecture to
reconcile the features learnt at each scale of the down-sampling pathway and take full advantage of the
information propagated, which may result in the deep network's degeneration. As shown in Figure 20, a
residual convolution block consists of two 3 x 3 convolution layers, followed by BN and ReLU activation
layers. The output of the residual block is then yielded by adding the input features to the outputs of the
stacked layers.

FIGURE 20: The residual block

E. Image Synthesis for Data Quality Enhancement and Augmentation
Deep convolutional networks have been enormously improved to provide cutting-edge solutions to
computer vision and they have given the ability to manipulate images for complex image-related tasks such
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as image synthesis, image reconstruction, image translation, etc. Recently, these tasks were significantly
treated thanks to the discovery of Generative Adversarial Networks (GANs) architecture. A standard GAN
comprises two models, a generator, and a discriminator. These models compete against each other to produce
fake data that is realistic enough to fool the discriminator. The architecture has known success in medical
imaging applications [140] and many variants were introduced such as conditional GAN (cGAN),
Wasserstein Generative Adversarial Network (WGAN), etc. Further work extended the idea to create
multiple GANs that can serve for synthetic data augmentation, domain adaptation, and style transfer. This
allowed using a pair of generators to learn mappings of images and a pair of discriminators to distinguish
two different types of images. The idea emphasized the image-to-image translation task that leverages
external labeled dataset to effectively reconstruct the source domain images with additional characteristics
of a target domain such as pixels, color distribution, shape, and texture. In this context, Pix2Pix and
CycleGAN are two common models that were developed to apply image-to-image translation techniques. As
shown in Figure 21, like the standard GAN, the two models have the target of translating images between
two domains. However, the difference is that the Pix2Pix model works with paired data sets but only accepts
one image from source domain (A) and indeed it corrects and updates the training using its corresponding
image from a target domain (B). Differently, CycleGAN model works with unpaired datasets, accepts two
images, and performs a cyclic translation across domains to return new synthetic images.
In fact, Pix2Pix [141] is based on conditional GAN (cGAN) architecture to learn a mapping between
images where the network is composed from a generator 𝐺𝐴→𝐵 and a discriminator D. The generator has an
encoder-decoder structure, and it tries to transfer special characteristics of an input image 𝑥𝑟𝐴 to get an output
image 𝑥𝑔𝐵 . The discriminator uses PatchGAN architecture, and it compares the input image to the generated
image on one time and the input image to the corresponding image from the external dataset 𝑥𝑟𝐵 another time
to update the generator learning.
Moreover, the Cycle Generative Adversarial Network, called CycleGAN [142], was designed to
learn mapping between images without the need to have correlations and one-to-one matches. The idea was
built on the top of Pix2Pix architecture but with the use of two generators 𝐺𝐴→𝐵 and 𝐺𝐵→𝐴 for cycled images
mapping and two discriminators 𝐷𝐴 and 𝐷𝐵 to distinguish between real and synthetic images. Additionally,
the CycleGAN technique employs a cycle consistency for the generators to ensure a good reconstruction of
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the new image back to their original look. Consequently, the technique helps to capture both domains’
features and style without mismatch.

FIGURE 21: Comparative scheme of standard GAN vs two variants for image-to-image translation: Pix2Pix and
CycleGAN

Given the limited size of annotated datasets and the difference of their resolutions, we propose to apply image
synthesis on our mammography datasets to improve the results of the segmentation. In a CycleGAN
architecture, a deep learning model learns the mapping pixel, color distribution, shape, and texture between
two datasets [143]. It has been considered as an effective deep learning technique for style transfer, domain
adaptation and data synthesis [144, 145, 146, 147]. Figure 22 details the CycleGAN architecture that
additionally evokes a cycle consistency for the generators G and F to ensure the reconstruction of the images
back to their original domains, where F(G(X)) = X and G(F(Y)) = Y. This helps the final model to capture
the characteristic features of the two domains and transfer the style without requiring any paired dataset.
Thus, the network uses the standard adversarial losses and a cycle consistency loss, defined as
‖𝐹(𝐺(𝑋)) − 𝑋‖1 + ‖𝐺(𝐹(𝑌)) − 𝑌‖1 .
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FIGURE 22: CycleGAN architecture for data synthesis

In this work, we developed the CycleGAN model using the tutorial available in Keras webpage
(https://keras.io/examples/generative/cyclegan). The architecture model has two generators and two
discriminators’ networks. The generator network consists of two down-sampling blocks with filter sizes
{128, 256}, nine residual blocks with filter size 256, and two up-sampling blocks with filter sizes {128, 64}.
The discriminator network is based on four down-sampling blocks with filter sizes {64, 128, 256, 512}. For
the Pix2Pix model, we similarly used two generators and two discriminators’ networks. The generator
network contains seven down-sampling and up-sampling blocks with filter sizes {64, 128, 256, 512, 512,
512, 512} and we used the same discriminator network from the CycleGAN architecture model.

F. Stacked Ensemble of Neural Networks for Tumors Classification and Diagnosis
In this step, we propose a stacked ensemble of models to classify and diagnose detected and segmented
breast masses. The base model comes from the ResNet architecture and its variations. Our methodology
employs different strategies: transfer learning, stacked ensemble learning, and image data augmentation.

1. ResNet base model: transfer learning and fine-tuning
Since its introduction, ResNet has been one of the recent architectures that has known common success
in medical imaging applications [148, 149]. ResNet is a deep CNN architecture suggested by He et al. [150]
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that uses residual blocks with skip connection between layers to bypass a few convolution layers at a time.
This new architecture accelerated the convergence of a larger number of deep layers, and consequently it has
been found efficient to provide a compact representation of input images and improve the classification task
performance [151]. The ResNet has some common architectures such as ResNet-50, 101, and 152, which
indicate the number of deep layers, but all use the same residual blocks containing three convolutional layers
with stride 1 and 3 followed by a Batch Normalization (BN) layer and a non-linearity layer Rectified Linear
Unit (ReLU) on its shortcut path [152]. Alternatively, ResNet architecture presented an improved version
ResNetV2 by He et al. [153], where the last ReLU was removed to clear the shortcut path using a simple
identity connection, as shown in Figure 23.

FIGURE 23: Residual block of ResNetV2

Our methodology employs three pre-trained ResNetV2 architectures, detailed below in Table 3. The
architectures accept RGB input images of size 224 x 224, and they are composed of an initial convolutional
layer with a filter size 7 x 7 and stride 2, followed by a pooling layer of size 3 x 3 and stride 2. The base
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architecture should then use four residual blocks with different kernel sizes of 64, 128, 256, and 512. Each
architecture has a different number of residual blocks that define the depth of layers. Finally, a global average
pooling layer with size 7 x 7 is used with a final fully connected layer (FC).
Table 3: ResNetV2 architecture layers

Layer Name

Output Size

ResNet50V2

Input Layer

ResNet101V2

ResNet152V2

224 x 224 x 3
Number of filters = 64

conv1

Filter size = 7 x 7

112 x 112 x 64

Strides = 2
Padding = 3
Strides = 2

pool1

56 x 56 x 64

conv2_x

56 x 56 x 64

1 ×1,
[3 × 3 ,
1 ×1,

64
64 ] x 3
256

1 ×1,
[3 × 3 ,
1 ×1,

64
64 ] x 3
256

1 ×1,
[3 × 3 ,
1 ×1,

64
64 ] x 3
256

conv3_x

28 x 28 x 128

1 ×1,
[3 × 3 ,
1 ×1,

128
128] x 4
512

1 ×1,
[3 × 3 ,
1 ×1,

128
128] x 4
512

1 ×1,
[3 × 3 ,
1 ×1,

128
128] x 8
512

conv4_x

14 x 14 x 256

1 ×1,
[3 × 3 ,
1 ×1,

256
256 ] x 6
1024

1 ×1,
[3 × 3 ,
1 ×1,

256
256 ] x 23
1024

1 ×1,
[3 × 3 ,
1 ×1,

256
256 ] x 36
1024

conv5_x

7 x 7 x 512

1 ×1,
[3 × 3 ,
1 ×1,

512
512 ] x 3
2048

1 ×1,
[3 × 3 ,
1 ×1,

512
512 ] x 3
2048

1 ×1,
[3 × 3 ,
1 ×1,

512
512 ] x 3
2048

Global average
pooling
Fully connected

Pooling size = 3 x 3

Pooling size = 7 x 7

2048

Strides = 7

1000

1 x 1 x 2048

Training a deep learning model often requires a large amount of annotated data that helps optimize
the high number of parameters and computations needed in the architecture. However, a limited size of
medical imaging datasets are usually available that suffer from either missing labels or imbalanced data
distribution. To overcome these challenges, transfer learning has been a common solution used in many
recent medical image application [154, 155] by training a model on a large and diverse dataset (i.e., ImageNet,
MSCOCO, etc.) to capture universal features like curves, edges, and boundaries in its early layers that are
relevant for image classification. After that, the pre-trained model should be alerted and fine-tuned on a
custom and specific dataset to reflect the final classification. This procedure provides a fast and generalizable
training of small datasets and avoids the overfitting problem that deep learning commonly suffers from.
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As Figure 24 indicates, we apply transfer learning to the base architecture ResNetV2 for our
proposed methodology to become a TF-ResNetV2. In fact, the model was initially pre-trained on ImageNet,
and then the first four residual blocks of layers were frozen with exception to the BN layers that needed to
be retrained to improve the training convergence. After that, the entire architecture was modified by adding
another FC layer with size of 1024, followed by a dropout regularization layer to maintain a generalization
aspect for the training. A new final FC layer was placed according to the number of classes for each
classification task and the entire TF-ResNetV2 is re-trained.

FIGURE 24: Framework of the classification base model: a TF-ResNetV2 model which is a ResNetV2 model pre-trained
on ImageNet data and modified and fine-tuned on mammography dataset

2. Stacked Ensemble of ResNet models for Breast tumors classification
Ensemble learning has been considered efficient to improve the classification task results. Combining
weaker classifiers to create a better final classification prediction has been adopted by either bagging,
boosting, or stacking models [156]. While bagging is achieved by learning independently from different
models and then averaging the predictions, boosting happens by sequentially learning from homogenous
learners and iteratively combining them into a final model. On the other hand, stacking has been considered
a way to learn different weak learners parallelly and combine them into a meta-model that is later trained to
achieve the classification prediction [157].
We propose a stacked ensemble of three different ResNet models to conduct our classification tasks.
After removing the last FC layer of each ResNetV2 architecture, a two-layer network is considered as a metaclassifier model that concatenates the three models’ layers, and stacks three different FC layers of size 1000,
100 and 10, coupled with activation functions Sigmoid and ReLU. As shown in Figure 25, pre-trained weights
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of each model were extracted as images features of size 1024 based on previous layer predictions and
considered as new input of the entire stacked ensemble of ResNet models for the final class prediction after
training independently ResNet50V2, ResNet101V2, and ResNet152V2.

FIGURE 25: Framework of the classification Stacked Ensemble of ResNet models

G. Integrated Framework of CAD system for Breast Cancer
Our final framework detects and localizes breast masses in a first step, and then segments them in a
second step. As a preparatory step before implementing the mass segmentation, an advanced dataenhancement method is used. This approach will not only improve the quality of low-resolution
mammograms, but it will also increase the size of mammography datasets.
In fact, the new architecture is used to apply to the ROIs of breast masses discovered in the previous
stage. Our framework applied the You- Only-Look-Once (YOLO) model in the previous step to locate
suspicious breast lesions and distinguish between mass and calcification lesions. As a result, the full
mammograms were used to forecast bounding boxes around worrisome items. At this stage, the architecture
is applied only on the ROIs of breast masses that were detected from the previous stage. Due to the lack of
ground truth annotation of the calcification lesions, only mass lesions segmentation is conducted in this study.
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Our framework applied the YOLO-based fusion model from the first step to locate suspicious breast
lesions and distinguish between mass and calcification lesions. Hence, the detected ROI masses are fed
directly into the second segmentation step using our new proposed architecture as shown in Figure 26. Given
the different scale of breast masses, our methodology expands some bounding boxes coordinates by adding
extra space around the small tumors. Thus, we obtain the ROI images, and we scale them into 256 x 256
pixels, which is the optimal input size found experimentally for segmentation networks.

FIGURE 26: The proposed integrated framework
(a) Original mammogram with ground truth of mass (red), (b) Detected ROI of mass (yellow) superimposed on the
original mammogram, (c) Detected ROI (i.e., input mass) obtained with ground truth (red), (d) Output segmented binary
mask of input mass, and (e) Segmented output mass where tissue is masked

After that, we enhanced the performance by integrating synthetic images as shown in Figure 27.
During the segmentation, the original detected ROI masses’ images and their generated synthetic images are
fed directly into the segmentation stage using our proposed architecture.

FIGURE 27: The proposed integrated framework
(a) Original mammogram with ground truth of mass (red). (b) Detected ROI of mass (yellow) superimposed on the
original mammogram. (c) Detected ROI (i.e., input mass) obtained with ground truth (red) (Domain X). (d) Detected
ROI obtained from a different mammography dataset (Domain Y). (e) Original ROI (Domain X) and Synthetic ROI
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(transferred from Domain Y to Domain X). (f) Output segmented binary mask of input mass. (g) Segmented output mass
where tissue is masked.

Finally, the segmented and detected ROI of breast masses generated with masked tissue are used
for the third and final classification step. The stacked ensemble of ResNet models is trained independently
on the input ROI masses for each classification task to finally predict the pathology as either malignant or
benign, the BI-RADS category with an assessment score between 2 to 6, or/and the shape as either round,
oval, lobulated or irregular. Therefore, the final framework is complete with all automated steps for breast
cancer analysis and diagnosis as shown in Figure 28.

FIGURE 28: The proposed integrated CAD framework
(a) Original mammogram with ground truth of mass (red), (b) Detected ROI of mass (yellow) superimposed on the
original mammogram, (c) Detected ROI mass obtained with ground truth (red), (d) Output segmented binary mask of
ROI mass, and (e) Segmented ROI mass with marked tissue.
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CHAPTER IV
EXPERIMENTAL RESULTS & DISCUSSION
A. Introduction
In this chapter, different experiments will be detailed to explain the evaluation of all proposed
methods and models. As mentioned before, the integrated framework of the CAD system was designed to
present a complete diagnosis of breast cancer as shown in the Figure 29. However, every step forming the
CAD system should return an output that was used somehow as an input of the consecutive step. Therefore,
all steps should be evaluated individually and together to ensure the final performance. The used
mammography datasets are annotated to help validate the learning and evaluation metrics were used
accordingly for each specific task. This chapter presents the datasets we used for this dissertation, details the
evaluation metrics, and finally reports the results of each proposed methodology.

FIGURE 29: The sequence of different experiments using the public and private mammography datasets
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B. Mammography Datasets
In this dissertation, we evaluated the proposed architectures models and methods on two public datasets,
the CBIS-DDSM and INbreast datasets and two private datasets that will be detailed in the subsections.

1. Public datasets
a. Curated Breast Imaging Subset of DDSM dataset
The Curated Breast Imaging Subset of DDSM (CBIS-DDSM) dataset [158] is an updated and
standardized version of the DDSM dataset, in which images were transformed from Lossless Joint
Photographic Experts Group (LJPEG) to Digital Imaging and Communications in Medicine (DICOM)
format. After removing incorrect samples, it was evaluated by radiologists and validated with
histopathological classification. It was reviewed by radiologists after eliminating inaccurate cases and
confirmed with the histopathology classification. It contains 2907 mammograms from 1555 patients, and it
is organized in two categories of pathology: Mass images (50.5%) and Calcification images (49.5%).
Mammograms were collected with two different views for each breast (i.e., MLO and CC) and samples are
presented in Figure 30. Original images have average size of 3000 × 4800 pixels and are associated with their
pixel-level ground-truth for suspicious regions location and type, and class labels annotation (i.e., Pathology,
BI-RADS category and Shape).
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FIGURE 30: Samples of mammograms from the CBIS-DDSM dataset. Cases with benign and malignant images of Mass
and Calcification lesions

b. INbreast dataset
INbreast [159] is a public dataset of images acquired using the MammoNovation Siemens Full-Field
Digital Mammography (FFDM) that are stored in DICOM format. Normal mammograms were eliminated
from the database, which comprises 410 mammograms, 235 of which had anomalies in both MLO and CC
views from 115 patents. Images are also represented with their annotated ground-truth and have average size
of 3328 × 4084 pixels. There are 45.5% of images that include Mass lesions and 54.5% of images that include
Calcifications lesions, and samples are shown in Figure 31.
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FIGURE 31: Samples of mammograms from the INbreast dataset. Cases with benign and malignant images of Mass and
Calcification lesions

2. Private Datasets
a. INCAN private collection
A private dataset was acquired from the National Institute of Cancerology (INCAN) in Mexico City.
It contains 489 mammograms with only stage 3 and 4 breast cancer (i.e., malignant) where 487 cases include
abnormal lesions from 208 patients, where 80% of images include Mass lesions and the rest includes
Calcifications. Images have an average of 300 × 700 pixels collected from CC, and MLO views. All
mammograms may have one or multiple lesions with different sizes and locations and are presented in Figure
32.
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FIGURE 32: Samples of mammograms from the INCAN private dataset. Only cases with malignant images of Mass and
Calcification lesions

b. UCHCDM private collection
Another collection of private datasets was acquired from the University of Connecticut Center
(UCHC), named UCHC DigiMammo (UCHCDM) database [160]. The dataset contains screening
mammograms of 230 patients, where each case had an initial screening, called Prior exam, and a second
follow-up screening between 1 to 6 years, called the Current exam, and samples are displayed in Figure 33.
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FIGURE 33: Samples of Prior and Current mammograms screenings
Row 1: Case# 31 for Right CC View and Prior exam 2.5 years. Row2: Case#14 for Left CC View and Prior exam 3 years.
(a) Prior exam with Normal mammogram (i.e., No diagnosis). (b) Current exam with Mass present.

This dataset was specially used for the early detection in prior screening views using a retrospective
analysis. Each screening in the dataset acquires two different views, CC, and MLO. All images were saved
with the Digital Imaging and Communications in Medicine (DICOM) format and were annotated by expert
radiologists in a description text file with corresponding pathology of a mammographic finding (i.e., Mass,
Calcification, Architectural Distortion, Normal), as shown in Figure 34. Pixel-level ground-truth images were
also provided separately where suspicious locations were circulated. A total of 413 mammograms are
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considered separately for Current (cancerous and healthy) and Prior exams (i.e., non-cancerous), and they
have an average size of 2950 x 3650 pixels.

FIGURE 34: Samples of Current mammograms screenings including cases with Mass, Calcification, and Architectural
distortion

3. Datasets annotation distribution
All the tasks that were conducted during the CAD system require ground-truth annotation and class
labels to train the machine learning techniques. The proposed methods and models should use labeled datasets
to classify the images according to each task and predict the outcomes precisely and accurately. All the deep
learning models we suggested in this dissertation are based on a supervised machine learning technique that
adjusts the model’s weights through iterations until the model is fitted appropriately. Each subsection below
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describes how the data is distributed according to the class labels that were truly annotated by experts and
radiologists.

a. Detection and Identification task
During the simultaneous detection and identification of abnormal lesions in mammograms, the
proposed YOLO-based fusion model should predict the class label probability of the detected bounding
boxes. The data that was fed to the model should have either single class labels, either Mass or Calcification,
or multiple labels. In this first step of the CAD system, we used the two public datasets, and the private
dataset and details are shown in Table 4. It is to mention that some mammograms may have one or multiple
lesions with different sizes and locations.
Table 4: Breast lesions data distribution

Dataset

Mass

Calcification

Total

Unique Patients

CBIS-DDSM

1,467

1,440

2,907

1,555

INbreast

107

128

235

410

INCAN

390

97

487

208

* We only consider images with existing Ground truth (pixel-level) for the segmentation task

b. Early detection of abnormalities in prior mammograms task
In this step, the first task of detection and identification was re-evaluated on an external private
dataset to detect different breast lesions and classify them into Mass, Calcification, or Architectural Distortion
and the rest to Normal as detailed in Table 5. After that, the proposed framework was furthermore developed
to integrate the Prior mammograms corresponding to all used follow-up screenings and provide an early
detection and classification on initial screened mammograms. The work evaluated the retrospective
prediction on Prior mammograms that were diagnosed as Normal but at a later stage, they were reported with
a clear presence and progress of abnormal findings.
Table 5: Current and Prior data distribution

Architectural

Dataset

Normal

Mass

Calcification

Prior views

413

0

0

0

Current views

42

181

116

74

56

distortion

Total

413

Unique
Patients
230

c. Mass segmentation task
After detecting the location of abnormal lesions and distinguishing between their types, the outcome
of the first step is coordinates of the ROI images that surround each abnormality and indicate their class label
probability. In this dissertation, we only focused on ROI masses due to the lack of pixel-level annotation of
other lesions in some datasets. Hence, the detected ROIs of only mass cases were retained for the second step
of segmentation and samples of entire mammograms and their ROI masses are illustrated in Figure 35. It can
be visually observed that the images have different resolution, and this is due to the different modality and
tools configuration that were used to acquire and store the mammograms.

FIGURE 35: Samples from the public and private mammography datasets with zoomed-in ROI of mass ground truth
(red). (a) Example from the CBIS-DDSM mammogram with MLO view, (b) Example from the INbreast mammogram
with MLO view, and (c) Example from the INCAN mammogram with CC view
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d. Tumor Classification and Diagnosis task
In the last step, after segmenting the detected ROI of masses, the predicted binary masks showing
only the tumors’ contours were applied on the ROIs images. The outcome of the second step should predict
the pixel-level labels to mask the background of the breast mass and emphasize the texture and the
morphology of the tumors. Figure 36 illustrates samples of original mammograms and their ROI masses
compared to the detected and segmented ROI masses from different datasets.

FIGURE 36: Samples of entire mammograms and ROI of detected and segmented Masses from different mammography
datasets with their ground-truth of location and contour in red

Each mammography dataset has a different quality of images in terms of pixel quality, existing
annotated labels, and class distribution, as detailed in Table 6, 7 and 8. In fact, only the CBIS-DDSM dataset
includes true class labels for lesions’ shape. Accordingly, the INbreast dataset indicates cases with BI-RADS
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score from 2 to 6, however the CBIS-DDSM dataset presents cases in the BI-RADS category 2 to 5, and both
INCAN and UCHCDM private datasets have only malignant cases as they indicate breast cancer cases from
only stage 3 and 4. Consequently, all mammograms from the private datasets fall into BI-RADS categories
4 and 5.
Table 6: Pathology class labels distribution for only Mass lesions

Pathology

Dataset

Benign

Malignant

CBIS-DDSM*

717

750

INbreast**

44

63

INCAN***

0

390

UCHCDM***

0

181

* Cases with Benign_without_callback are considered Benign
** Cases with BI-RADS score > 3, are considered Malignant otherwise Benign
*** Only Malignant Cases with BI-RADS score = 4 and 5
Table 7: BI-RADS category class labels distribution for only Mass lesions

BI-RADS

Dataset
Category 2

Category 3

Category 4

Category 5

Category 6

CBIS-DDSM

189

323

388

567

0

INbreast

22

13

21

43

8

INCAN

0

0

211

287

0

UCHCDM

0

0

105

76

0

Table 8: Shape class labels distribution for only Mass lesions

Dataset
CBIS-DDSM

Shape
Round

Oval

Lobulated

Irregular

132

341

352

642

4. Data preparation
All mammogram images were collected using the scanning technique of digital X-Ray mammography
that usually compresses the breast. The technique may generate deformable breast regions and degrade the
quality of mammography images [161, 162]. Therefore, some preprocessing steps could be applied to correct
the data and remove additional noise [47, 63]. In this work, we only applied the histogram equalization
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technique on the public and private datasets to enhance any compressed region and create a smooth pixelequalization that could help distinguish suspicious regions from the normal regions.
Furthermore, our suggested YOLO-based model requires input mammograms and their corresponding
ground-truth coordinates of regions of interest (ROI) that surround the breast lesions. According to the
existing annotation that represents the experts’ annotations, we extracted the lesion coordinates represented
in x, y, width and height and the class (Mass or Calcification) accordingly. Next, all mammograms were
resized using a bi-cubic interpolation over a 4 x 4 neighborhood. For experimental reasons, we used images
sizes of 448 x 448 because the input size should be divisible by 32 according to DarkNet backbone
architecture of YOLO-V3, and this size should also fit on the GPU memory. Samples of original and
preprocessed images are illustrated below in Figure 37.

FIGURE 37: Samples from Current exams of original (upper row) and preprocessed mammograms (bottom row)

Deep learning models require a huge quantity of labeled data to be trained, which improves in their
generalization. For medical applications, most of the collected datasets have small numbers of instances and
often suffer from an imbalanced distribution, which remains a challenge for training deep learning models
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[163]. Many researchers have lately used two techniques to solve this problem: data augmentation and
transfer learning. Data augmentation is a technique for extending the quantity of a dataset in an experimental
setting. In this work and for the detection task, we augmented the original mammograms six times. First, we
rotated original images with the angles Δ𝜃 = {0°, 90°, 180°, 270°} and we transformed them using Contrast
Limited Adaptive Histogram Equalization (CLAHE) method [164] with two variations {tile grid size of (4,
4) and a contrast threshold of 40, tile grid size of (8, 8) and a contrast threshold of 30}. Thus, a total of 18,909;
1,410; 2,922 and 1,652 mammograms were respectively collected for the CBIS-DDSM and INbreast public
datasets, and the INCAN and UCHCDM private datasets to train and test the proposed model.
The initialization of the trainable parameters is the first step in deep learning models (i.e., weights,
biases). To do that, there are two commonly adopted methods: random initialization and transfer learning
[165, 166]. We exclusively used the transfer learning approach in our work, which involved applying the
weights of a pre-trained model on a larger annotated dataset (i.e., ImageNet, MSCOCO, etc.) and then retraining and fine-tuning the new weights on our unique task and augmented dataset. This helped to accelerate
the convergence and avoid overfitting problems. As a result, we employed the weights that were learned on
the Microsoft COCO dataset using the DarkNet backbone architecture. The pre-trained model architecture
was originally based on the VGG-16 model.
In the segmentation stage, only detected and classified masses from the two public dataset and the
INCAN private dataset there were correctly predicted by the YOLO model were considered and the false
predictions were discarded as similarly highlighted in previous works [167, 168]. The UCHCDM private
dataset was not used because it does not acquire pixel-level annotation.
Some cases of mammograms have more than one detected mass lesion, therefore, a total of 1,467,
112, and 638 masses were respectively considered from the CBIS-DDSM, INbreast, and the INCAN dataset.
Because our network only works on single detected ROIs, we wanted to examine mammograms with multiple
lesions at the detection stage and treat them as single mass lesions ROIs. The estimated ROI masses were
then downsized into 256 x 256 using either a bi-cubic interpolation or an inter-area resampling interpolation,
depending on whether the original size was small or big. All images were preprocessed to remove additional
noise and degradation caused by the scanning technique of digital X-ray mammography [49, 80]. As a result,
we used histogram equalization to improve the compressed regions and smooth the pixel distribution, which
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also improves the pixel segmentation. All images were normalized to a range of [0, 1]. Samples of ROI
images of masses and their pixel-level mapping are shown in Figure 38.
To generalize the learning curve of the proposed segmentation deep learning models, many
annotated samples need to be provided. Because each dataset has a restricted number of ROI masses, we
have augmented the original ROIs four times by rotating them at angles of 0°, 90°, 180°, and 270°. We also
used the Contrast Limited Adaptive Histogram Equalization (CLAHE) approach to alter them twice. To train
and evaluate the suggested architectures, raw data of single ROI images were augmented six times into a
total of 8,802; 672, and 3,828 ROI masses were prepared, respectively, from the CBIS-DDSM, INbreast, and
INCAN private datasets.

FIGURE 38: Samples of ROI masses and their ground-truth masks from each mammography dataset used for
segmentation

Finally, the detected and segmented ROIs from the previous steps are used for the last classification
and diagnosis step. The outcome of the last third step defines the diagnostic decision of the CAD system that
provides a class label probability of the pathology, the BI-RADS category or/and the shape. Furthermore, the
pre-trained ResNet models, which were used for the last step, require input image size of 224 x 224; therefore,
the detected and segmented ROIs were down sampled from 256 x 256 using an inter-area resampling
interpolation. Finally, all images were normalized to a range of [0, 1]. Samples of input data for each
classification class are illustrated in Figure 39 where ROIs are distributed according to different class labels
from the mammography datasets.
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FIGURE 39: Samples of the detected and segmented ROI masses for each class within different classification tasks from
different mammography datasets

C. Evaluation Metrics & Experiments Setups
1. Detection and Identification metrics
In this dissertation, we used only object detection and identification measures to evaluate the
performance of our proposed YOLO-based model. To ensure the true detection of breast lesions in the
mammograms, we first measured the intersection over union (IoU) score between each detected box and its
ground-truth (i.e. (x, y, h, w) coordinates and class label), and then we verified if it exceeded a particular
confidence score threshold of 0.35 that will be discussed later. Eq. (1) details the IoU score formula.
𝐴𝑟𝑒𝑎 𝑜𝑓 𝐼𝑛𝑡𝑒𝑟𝑠𝑒𝑐𝑡𝑖𝑜𝑛
(1)
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑈𝑛𝑖𝑜𝑛
We also used an objective metric that considered the genuine detected boxes' estimated class
𝐼𝑜𝑈 𝑠𝑐𝑜𝑟𝑒 =

probability. Inspired by the work [139], we computed the number of true detected masses and calcifications
over the total number of mammograms as defined in Eq. (2).
𝐷𝑒𝑡𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦 𝑟𝑎𝑡𝑒 =

𝑇𝑟𝑢𝑒 𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 𝑐𝑎𝑠𝑒𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑎𝑠𝑒𝑠

(2)

This means that before estimating the final detection accuracy rate, we removed cases with a lower
IoU score. Predicted boxes with confidence probability scores equal to or greater than the confidence score
threshold were only considered when calculating the final detection accuracy rate. We measured the detection
accuracy rate globally and for each independent class to evaluate the performance of the simultaneous
detection and classification.
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2. Retrospective early detection metrics
In this part, the YOLO-based fusion model was trained on the Current views of the UCHCDM private
dataset. The same evaluation metrics for detection and identification were used as explained above.
Additionally, we particularly reported the Current mammograms prediction results using the area under curve
(AUC) that reflects the performance of the model and the trade-off between the true positive rate and false
positive rate for each target class label. We used three additional metrics called precision, recall, and
sensitivity that are computed using the TP, FP, and FN that are defined per predicted class to represent the
number of true positive, false positive, and false negative predictions, respectively as shown in Eq. (3), Eq.
(4), and Eq. (5).
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
𝑇𝑃
𝑅𝑒𝑐𝑎𝑙𝑙 =
𝑇𝑃 + 𝐹𝑁

𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =

(3)
(4)

𝐹𝑁
(5)
𝐹𝑁 + 𝑇𝑃
The early detection of abnormalities in Prior mammograms was evaluated using two metrics, a true
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 = 1 − 𝐹𝑁𝑅 = 1 −

prediction rate and false prediction rate. We considered a true prediction where the location and type of breast
lesions were correctly captured using the inference model, retrospectively on non-cancerous screening views
at t=0 years. The inference evaluation was concluded using the ground-truth labels of the Current views that
were generated by experts later at t= [1, 6] years. Consequently, all predictions should be fairly compared to
0 predictions (i.e., all were missed) by experts at t=0. Both metrics were compared to the “Experts prediction”
that missed detecting the risk of future breast cancer.

3. Segmentation metrics
Segmentation stage is evaluated using the Dice similarity score, also called F1-score, which
represents a coupled average of the intersection between areas and the total areas as indicated in Eq. (6).
Accordingly, we use another evaluation metric, the Intersection Over Union (IoU) score, also called the
Jaccard score, which is detailed in Eq. (7). The pixels surrounding all the masses are correctly segmented,
resulting in a binary mask being formed from the segmented contour of the mass lesions with a high Dice
score and IoU score.
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𝐷𝑖𝑐𝑒 𝑠𝑐𝑜𝑟𝑒 (𝐴, 𝐵) =

2 × 𝐴𝑟𝑒𝑎 𝑜𝑓 𝐼𝑛𝑡𝑒𝑟𝑠𝑒𝑐𝑡𝑖𝑜𝑛(𝐴, 𝐵) 2 × (𝐴 ∩ 𝐵)
=
𝐴𝑟𝑒𝑎 𝑜𝑓 (𝐴) + 𝐴𝑟𝑒𝑎 𝑜𝑓 (𝐵)
𝐴+𝐵

(6)

𝐴𝑟𝑒𝑎 𝑜𝑓 𝐼𝑛𝑡𝑒𝑟𝑠𝑒𝑐𝑡𝑖𝑜𝑛 (𝐴, 𝐵) 𝐴 ∩ 𝐵
=
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑈𝑛𝑖𝑜𝑛 (𝐴, 𝐵)
𝐴 ∪ 𝐵

(7)

𝐼𝑜𝑈 𝑠𝑐𝑜𝑟𝑒 (𝐴, 𝐵) =

To train the proposed architecture models, a learning rate of 0.0001 with Adam optimizer is
employed. A weighted sum of Dice and IoU losses is used as a segmentation loss function using the Dice
score and IoU score between true and predicted samples, as detailed in Eq. (8).
𝑆𝑒𝑔𝑚𝑒𝑛𝑡𝑎𝑡𝑖𝑜𝑛 𝑙𝑜𝑠𝑠(𝑡𝑟𝑢𝑒, 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑)

(8)

= −(0.4 × 𝐷𝑖𝑐𝑒 𝑠𝑐𝑜𝑟𝑒(𝑡𝑟𝑢𝑒, 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑) + 0.6 × 𝐼𝑜𝑈(𝑡𝑟𝑢𝑒, 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑))
To evaluate our integrated framework system, we first define a segmentation accuracy measure
to be the mean IoU score for correctly identified ROIs based on a 90% overlap threshold and we refer to it
as IoU90 score as shown in Eq. (9). Then, a final segmentation accuracy is introduced as an end-to-end
accuracy for the two stages, explained in Eq. (10).
𝐼𝑜𝑈90 𝑠𝑐𝑜𝑟𝑒 = {𝑚𝑒𝑎𝑛 (𝐼𝑜𝑈 𝑠𝑐𝑜𝑟𝑒𝑠 ∀ 𝑅𝑂𝐼𝑠)
≥ 90 𝑁𝑜𝑡 𝑎𝑝𝑝𝑙𝑖𝑐𝑎𝑏𝑙𝑒

𝑖𝑓 𝐼𝑜𝑈 𝑠𝑐𝑜𝑟𝑒 (𝐴, 𝐵)

(9)

𝑖𝑓 𝐼𝑜𝑈 𝑠𝑐𝑜𝑟𝑒 < 90

𝐹𝑖𝑛𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑎𝑡𝑖𝑜𝑛 𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦 = 𝐷𝑒𝑡𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦 𝑟𝑎𝑡𝑒 × 𝐼𝑜𝑈90 𝑠𝑐𝑜𝑟𝑒

(10)

4. Classification and Diagnosis metrics
All classification tasks are evaluated overall using the accuracy, and area under curve (AUC) that
reflect the performance of the model while considering the unbalanced mammography datasets. Particularly,
for pathology classification, which presents a binary-class case, we use three additional metrics called
sensitivity, specificity scores, and F1-score, as shown in Eq. (11), Eq. (12), and Eq. (13). The F1-score is a
coefficient that represents a harmonic average between the specificity and sensitivity, where its maximum
score of 1 indicates perfect specificity and sensitivity and of 0 the worst performance. Moreover, the accuracy
score is a rate of correct predictions over all cases as detailed in Eq. (14) where TP, TN, FP, and FN are
defined per predicted class to represent the number of true positive, true negative, false positive, and false
negative predictions, respectively.
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =

𝑇𝑃
𝑇𝑃 + 𝐹𝑁
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(11)

𝑇𝑁
𝑇𝑁 + 𝐹𝑃

(12)

2 × 𝑇𝑃
2 × 𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁

(13)

𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =
𝐹1 − 𝑠𝑐𝑜𝑟𝑒 =
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =

𝑇𝑟𝑢𝑒 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛
𝑇𝑃 + 𝑇𝑁
=
𝑇𝑜𝑡𝑎𝑙 𝑐𝑎𝑠𝑒𝑠
𝑇𝑃 + 𝐹𝑃 + 𝑇𝑁 + 𝐹𝑁

(14)

In the pathology classification, positive refers to the malignant class and negative refers to the
benign class. In the BI-RADS category and shape classification, macro-averaging is used to compute the
accuracy and the AUC scores. Consequently, a confusion matrix can be driven from these measurements to
show the tradeoff between the true and predicted class labels.

5. Experimental setups
The proposed YOLO-based model presents a list of hyperparameters that includes learning rate,
number of epochs, dropout rate, batch size, number of hidden units, confidence score threshold and so on.
Only three hyperparameters were chosen for tuning because of their impact on the model's performance. For
all datasets, we randomly split all mammograms for each class into groups of 70%, 20%, and 10%
respectively for training, testing, and validation sets.
Trainable parameters were kept constant while hyperparameters were modified in each experiment.
Adam was used to optimize all experimental datasets, and the detection accuracy rate was utilized to report
all experiments. First, we set the learning rate to 0.001, number of epochs to 100 and the batch size to 64
according to the work [47], and then we trained the model with different confidence score thresholds until
we report the value that provided satisfying detected objects for further tasks (i.e., segmentation and shape
classification). As shown in Figure 40a, the best confidence score value for all datasets is 0.35 to accept all
detected objects the model confident from them by more than 35%. Next, we repeated the experiments, but
we varied learning rate values to report the best detection accuracy rate for all datasets as shown in Figure
40b. In addition, the early stopping strategy for the second half of iterations was used to reduce the learning
rate by 10% if the loss function did not decrease every 10 epochs.
Next, we selected the best learning rate, which is 0.001, and we varied the batch size to report the
best results for the three datasets as illustrated in Figure 40c. Finally, we modified the number of epochs until
all datasets indicated the greatest performance for 100 epochs, as shown in Figure 40d.
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FIGURE 40: Hyperparameters tuning; (a) confidence score; (b) learning rate; (c) batch size and (d) number of epochs

Similarly, for the segmentation step, each mammography dataset is randomly split into groups of
70%, 20%, and 10%, respectively, for training, testing, and validation sets as detailed in Table 9. It is
important to highlight that some of the raw MGs have multiple ROIs. Accordingly, 100 epochs and 8 mini
batches were used to optimize the network parameters with the training and validation sets.
Table 9: Data distribution of the mammography datasets

Raw

Raw

Augmented

MGs

ROIs

Data

Data

Data

(ROIs*6)

1,467

1,467

INbreast

107

INCAN

389

Dataset

CBISDDSM

Training

Testing

Validation

Data (70%)

Data (20%)

Data (10%)

8,802

6,161

1,760

881

112

672

470

134

68

638

3,828

2,679

766

383

Furthermore, for the two image-to-image translation models, they were trained and evaluated on
100 epochs and optimized using the Adam technique with learning rate of 0.0002 and beta score of 0.5.
During the early detection on prior mammograms, the YOLO-based fusion model was differently evaluated
using a 5-fold cross validation by training and testing the model using different test sets of random
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mammograms to ensure the model robustness. Consequently, the entire UCHCDM dataset was randomly
divided into equal 5 folds of 1,324 training images (80%) and 328 testing images (20%) with respect to the
imbalanced classes as detailed in Table 10. Finally, we reported the average of results over all the folds.
Table 10: Cross Validation Folds: Data distribution across class labels

Breast Lesions
Data

Normal

Overall

243

130

1,324

92

60

32

328

465

303

162

1,652

Mass

Calcification

Training

578

373

Testing

144

Total

722

Architectural
Distortion

For all experiments using the YOLO-based model, we set the learning rate to be 0.001, the batch
size to be 8, and the number of epochs to be 100. The loss function combined the bounding box regression
loss, the class label loss, and the confidence loss. All functions were based on cross-entropy, and they were
scaled to handle the imbalance of class labels on each batch. In addition, the early stopping method was used
for the second half of iterations to dynamically reduce the learning rate by 10% every 10 epochs in case of
constant loss function value. To prevent overfitting, all models were initialized by weights from a pre-trained
model on a large public dataset, MSCOCO. Then, the models were re-trained and new layers were fine-tuned
on our mammography dataset.
Finally, during the classification and diagnosis step, extensive experiments with different variations
in hyperparameters were conducted to select the best parameters for the base ResNetV2 model. Considering
their effect on the classification performance, only hyperparameters detailed in Table 11 were tuned to select
the best configured network that outperforms the evaluated networks on all mammography datasets.
Table 11: Hyperparameters for the ResNetV2 base model

Hyperparameters

Values explored

Description

Batch size

32, 64

mini-batch training size

Epochs

20, 30, 50

Number of training epochs

Dropout

0%, 20%, 30%

% of neuron of hidden layers “dropped” for regularization

LR

10-1, 10-2, 10-3

Learning rate for the Adam optimizer

Smoothing

0% 20%, 25%

% of label smoothing for the loss function
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For all datasets, we randomly split images for each class into groups of 80% for training, 20%
divided equally between testing and validation sets. In each experiment, the same trainable parameters were
used and each hyperparameter was varied accordingly. For all datasets and classification tasks, we used Adam
optimized and evaluation was reported with a weighted accuracy score to reflect the class imbalance during
the training and testing. The loss function was employed according to the classification task, a Binary Crossentropy function for binary classes and Categorical Cross-entropy for multiple classes. In both cases, a label
smoothing technique for regularization to help overcome overfitting and provide a generalized model. The
technique works by explicitly updating the labels during the loss function and decreasing the model’s
confidence when it starts diverging [169]. In addition, training was monitored using a method that reduces
the learning rate if the accuracy stops improving. Thus, we applied the stated strategy with a factor of 0.5
when the accuracy did not improve after two iterations. Conclusively, the best evaluation was reported with
a batch size of 32, 30 epochs, a dropout rate of 30%, a learning rate of 10 -2, and a smoothing label of 25%.

D. Evaluation Results
All experiments using the proposed methods were conducted on a PC with the following
specifications: Intel(R) Core (TM) i7-8700K processor with 32 GB RAM, 3.70 GHz frequency, and one
NVIDIA GeForce GTX 1090 Ti GPU. Python 3.6 was used for conducting all experiments.

1. Detection and Identification
During the first step of the CAD system, different experiments were conducted to assess the effect
of varying input images data and target classes (i.e., Mass, Calcification) of our suggested YOLO-based
model. To improve the outcomes, more tests were undertaken with the fusion model’s technique.

a. Single Models Evaluation
The breast lesions detection and classification model was trained differently over the mammography
datasets. We varied the input data fed to the model and configured the classification to be with multiple
classes using M2. Performance of the model is reported in Table 12.
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Table 12: Model performance for different configurations

Dataset

CBISDDSM

Configuration

Overall Detection accuracy

Inference time per

rate (%)

image (s)

63.7

1.23

73.7

0.57

75.2

0.98

81.7

0.57

62.4

0.79

92

0.57

Original images + Original size
Augmented images + Resize
448 x 448
Original images + Original size

INbreast

Augmented images + Resize
448 x 448
Original images + Original size

INCAN

Augmented images + Resize
448 x 448

Results show the advantage of data augmentation and resize over the original mammography
datasets. In fact, the performance increased with 10% for CBIS-DDSM dataset with almost half of inference
time. Similarly, the model achieved a better detection accuracy rate with more than 6.5% and 40% less
inference time. The same improvement with 29.6% is noticed on the INCAN private dataset with a 28%
drop-in inference time. Accordingly, using the augmented and resized datasets, we varied the prediction
classes by training M1 independently on Mass and Calcification, and M 2 on both, and results are reported in
Table 13 below
Table 13: Model performance for different prediction classes

Detection accuracy rate (%)
Dataset

Model1

Inference time per image

Model2

(s)

Mass

Calcification

Mass

Calcification

Overall

CBIS-DDSM

85.1

62.2

84.7

60.2

73.7

0.55

INbreast

93.4

71.8

93.1

68.7

81.7

0.58

INCAN

97.9

68.5

96.2

67.8

92

0.52

Results show that INCAN private dataset had the highest performance compared with the public
datasets and this can be explained with the good resolutions and the easy localization of most of the lesions
in those mammograms. Furthermore, the public datasets had more degraded lesions, which are more difficult
to identify and classify at the same time. Accordingly, results in Table 13 show the clear ability of the YOLObased model to better detect and classify the mass lesions from the entire mammograms than the calcification
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lesions. This corresponds to the differences in shape, size, and texture of the two types of lesions. In fact,
calcifications are often small and randomly distributed in challenging positions within the breast [170]. As
shown in Figure 41, calcifications do not have standard shape and they can be bilateral, thick linear, clustered,
pleomorphic, and vascular, etc. These varied shapes can limit the detection and classification for this type of
lesions and yield more failed cases than for the other lesions. Below in Figure 41, it shows a case of a coarselike calcification that has crossed thick lines with irregular size (image on the left, taken from the CBISDDSM dataset). Pleomorphic calcifications with a random distribution are seen in another example (image
on the middle, taken from the INbreast dataset). In addition, an example of clustered calcifications located
on the pectoral muscle that presents a challenging case in mammography (image on the right, taken from the
INCAN private dataset).
Moreover, we notice that both models have the best results toward mass lesions using the INCAN
private dataset, and toward calcification lesions using the INbreast dataset. This can be explained with the
degraded quality presented in the digitized X-rays mammograms of CBIS-DDSM dataset. Consequently,
performance is affected by the image quality and our study proved that detection and classification highly
require full-field digital mammography images which involve direct conversion and preserve the shape and
textures of breast lesions [171].

FIGURE 41: Examples of different calcifications shape and localization (ground-truth of calcification is marked in green,
ground-truth of mass is marked in red) for CBIS-DDSM, INbreast and INCAN private datasets (from left to right)
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Moreover, Table 13 demonstrates that training the model on both prediction classes slightly
decreased the performance and this can be explained by the inability of the YOLO-based model to detect and
distinguish some different types of lesions having similar shapes. However, we proved the robustness of our
suggested model toward mass detection with a maximum detection accuracy rate of 96.2 using the private
dataset. Inference time was similar in all studies, with a maximum of 0.58 seconds. Examples from each
dataset are illustrated in Figure 42, and each lesion's breast has its confidence score. Multiple lesions were
accurately discovered in the same mammogram, as we can see.

FIGURE 42: Examples of breast lesions detection and classification results and their confidence score toward different
classes on CBIS-DDSM, INbreast and INCAN private datasets (from left to right): mass (green boxes) and calcification
(yellow boxes)

b. Fusion Models Evaluation
To test the simultaneous detection and classification model, this study introduced an additional step.
It presents an expanded evaluation which fuses models that are trained with different settings as detailed in
the previous chapter. In fact, before presenting the results, single models M1 and M2 were first reported over
best-selected mammograms from the augmented datasets. This means for every set of predicted
mammograms including the original and their five augmented images (i.e., rotated, transformed), we selected
the image having the highest IoU score. Next, different models were fused into a new Fusion model, as
detailed in Table 14, and we measured the detection accuracy rate toward every prediction class.
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Table 14: Comparison performance using fusion models’ approach

Detection accuracy rate (%)
Dataset

Model1

Model2

Fusion model

Mass

Calcification

Mass

Calcification

Mass

Calcification

CBIS-DDSM

85.1

62.2

84.7

60.2

95.7

74.4

INbreast

93.4

71.8

93.1

68.7

98.1

72

INCAN

97.9

68.5

96.2

67.8

98

73.2

Indeed, the performance of detection and classification using the fusion model was increased for
each type of breast lesion compared to the single models. For the CBIS-DDSM dataset, mass lesions had a
detection accuracy rate of 95.7%, which is higher than 85.1%. Besides, we boosted the performance with
12.2% for calcification lesions. For the INbreast dataset, we achieved a final detection accuracy rate of 98.1%
for mass lesions and 72% for calcification lesions, which are better than results reported for single
experiments in Table 13. Similarly, performance was improved for the private dataset with 98% detection
accuracy rate for mass lesions and 73.2% for calcification lesions.
Our proposed fusion models significantly increased the detection and classification outcomes on
mammography pictures, as can be seen. Indeed, fusion strategies were reviewed in the past for medical image
segmentation [172, 173, 174], and our approach is a new decision-level fusion strategy for object detection
and classification that proved the advantage of fusing results of multiple models.
Finally, a comparison of mass detection results of the latest studies and similar methods are listed in
Table 15. Our method, which is based on fusion models, is sufficiently fast and accurate. Comparing both
detection accuracy rate and inference time with the other works shows that we achieved a better overall
performance on the public datasets: CBIS-DDSM with a detection accuracy rate of 95.7% and INbreast with
a detection accuracy rate of 98.1%.
It's worth noting that comparing results with state-of-the-art approaches were based on both detection
accuracy rate and testing inference time, thus while Al-Antari et al. [62] exceeded the INbreast detection
results, it was more expensive in terms of inference time than our implementation. Furthermore, the trials in
each paper used distinct preprocessing strategies that performed differently on both standard datasets. The
framework of the YOLO-based fusion model for the detection and identification of breast cancer
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abnormalities was published in the Computers, Materials & Continua Journal at the Recent Advances in Deep
Learning for Medical Image Analysis Special Issue [175].
Table 15: Comparison of mass detection with other works

Detection
Reference

Year

Method

Dataset

accuracy rate
(%)

Dhungel et al.
[167]

Inference time
per image (s)

Cascade Deep
2017

Learning and

INbreast

96

39

INbreast

87

108

CBIS-DDSM

82

Random Forest

Kozegar et al.
[31]

Adaptive
2013

threshold
machine learning
CNN patch

Agarwal et al.
[32]

2019

classifier and

NA

mass probability
map (MPM)

INbreast

98

INbreast

89.5

CBIS-DDSM

93.45

INbreast

95.54

Aly, G. et al. [52]

2021

YOLO

Peng et al. [61]

2020

Faster R-CNN

2018

YOLO

INbreast

98.96

3

2020

YOLO

INbreast

97.27

0.025

INbreast

97

NA

CBIS-DDSM

95.7

0.55

INbreast

98.1

0.58

INCAN

98

0.52

Al-Antari et al.
[62]
Al-Antari et al.
[63]
Singh et al. [89]

Proposed
Methodology

2020

2021

Single Shot
Detector (SSD)
YOLO-based
Fusion Models

0.009
0.134

2. Early detection of abnormalities in prior mammograms
a. Evaluation of YOLO-based model on Current Mammograms
First part of the study considered only Current mammograms from the most recent screening exams.
The YOLO-based models were trained differently over the Current views of the UCHCDM private dataset.
We varied the models according to the input dataset and the target class. Hence, Model1 was configured for
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single classes and Model2 was configured for mixed classes. Finally, the Fusion Model was designated to
combine Model1 and Model2 for each target class according to the approach previously. Table 16 shows
quantitative comparison of the detection accuracy rate and count that were reported using the 5-fold cross
validation as μ ± σ, where μ and σ refer to the mean and standard deviation, respectively.
Table 16: Comparison performance for different models across labeled classes on Test sets

Breast Lesions
Models

Model1

Model2

Results

Count
μ±σ

Count
μ±σ

Fusion

Count

Model

μ±σ

Mass

113
79% ±
0.09
110
76% ±
0.03
135
93% ±
0.118

Calcification

Architectural

Normal

Overall

Distortion

74

49

80% ± 0.05

82% ± 0.03

79

51

86% ± 0.04

85% ± 0.02

81

57

88% ± 0.09

95% ± 0.06

Inference time
per image
(sec)

25

261

78% ±

79% ±

0.01

0.04

28

268

87% ±

82% ±

0.05

0.03

30

303

94% ±

92% ±

0.11

0.09

0.60

0.62

0.62

Results show the advantage of the adapted Fusion Model and confirm its highest results overall and
for each class label. Fusion Model had the highest score of 95% for Architectural Distortion lesions and a
score of 92% overall. Moreover, results in Table 16 show the ability of YOLO architecture to detect and
classify the breast lesions with a maximum accuracy rate of 93% for mammograms with Mass lesions, 88%
for mammograms with Calcification lesions, and 95% for mammograms with Architectural Distortion
lesions. Appropriately, Normal mammograms were also correctly classified with a maximum accuracy score
of 94% where no bounding boxes were detected. All experiments had similar inference time with a maximum
value of 0.62 seconds per image.
Additionally, to get a better understanding of the models’ performance, we generated the freeresponse receiver operating characteristic (FROC) curves to illustrate the number of false positives per image
(FPI) for each target class label. Plots of the FROCs between Average sensitivity and the average number of
false positives are shown in Figure 43 that specifically compares Model1, Model2, and the Fusion Model.
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FIGURE 43: FROC curve plots of the YOLO based proposed Detection and identification models per class label on Test
sets

By varying the threshold and the range of false positives between 0.05 and 0.20 overall, we could
achieve an average sensitivity between 0.7 and 0.95 for all cases. Figure 43 clearly shows that the Fusion
model had the highest performance compared to the other evaluated models. It is observed that the proposed
model could obtain an average sensitivity of more than 0.90 with an average FPI of 0.20 for Mass lesions, an
average sensitivity of more than 0.85 with an average FPI of 0.12 for Calcification lesions, and an average
sensitivity of more than 0.90 with an average FPI of 0.175 for Architectural Distortion lesions. Accordingly,
Normal cases in Current views were evaluated using the FROC analysis and a false positive was considered
when no detection should have occurred in a non-cancerous case, but it was missed by the model. It is to
notice that we could obtain an average sensitivity of around 0.95 with an average FPI of 0.20.
Finally, we analyzed the performance results with a particular focus on the classification task that
was conducted by the YOLO-based Fusion model. Table 17 explores the calculated classification metrics by

76

each class label, where we achieved the highest sensitivity of 94.11% on the cancer cases with Architectural
Distortion and a sensitivity of 92.09% on the non-cancerous cases.
Table 17: Performance results for Detection and Classification on Test sets

Class Label

Accuracy

Precision

Recall

Sensitivity

AUC

Mass

0.94

0.94

0.94

0.93

0.95

Calcification

0.93

0.88

0.88

0.88

0.94

Architectural Distortion

0.98

0.95

0.95

0.94

0.95

Normal

0.98

0.94

0.94

0.92

0.96

Additionally, Figure 44 illustrates a visual comparison of the trade-off between the false positive
rate (FPR) and the true positive rate (TPR) according to the ROC curve plot between the different cases. We
observed a highest AUC score of 0.95 for the Mass and the Architectural Distortion cases, and an AUC score
of 0.96 for the Normal cases. The low results for the Calcification lesions could be explained with the fact
that this type of breast lesions do not have standard shape and location and they are often small and randomly
distributed which can limit the automatic detection.

FIGURE 44: ROC curve plots of the proposed YOLO-based Fusion Model per class label on Test sets

Moreover, Figure 45 illustrates the confusion matrix for the classification of the true detected
bounding boxes applied on the Current mammograms, where three types of lesions are presented with the
Normal cases (i.e., correct prediction without detected lesions). Clearly, the prediction error for different
classes is low with a high rate of 6.2% corresponding to the Normal class label and 7.6% corresponding to
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the Calcification cases. The distribution of error within classes could be explained by the inability of the
YOLO-based model to detect and distinguish some different types of lesions having similar shapes such as
Calcification and Architectural Distortion that often have irregular shapes in challenging positions within the
breast.

FIGURE 45: Confusion matrix of prediction results for Current Mammograms

b. Evaluation of YOLO-based model on Prior Mammograms
Second part of the study focused on using the pairs of mammograms, including current views and
their Prior screening exams to provide an early detection and classification of lesions on the Prior screening
exams. All Prior mammograms were not annotated with diagnosis and thus were considered Normal (i.e.,
non-cancerous, corresponding to 0s in “Experts prediction” row in Tables 18a, 18b, and 18c). In this part, we
introduce a retrospective approach to look back at the Prior mammograms and try to explore any patterns of
breast lesions before waiting on a follow-up screening.
Our methodology is based on joining the learned mapping between the temporal views and a trained
model on Current mammograms that were annotated by experts. First, the pairs of datasets were prepared
using the same configuration, and two image-to-image translation models were trained between the two
datasets to determine the images mapping. Consequently, synthetic mammograms from Prior screening
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exams were generated to resemble the Current mammograms and preserve the general texture of the Prior
mammograms.
After that, the YOLO-based model that was trained and validated previously on the Current mammograms,
was saved, and used for inference on Prior mammograms. Experiments were evaluated using only the Fusion
Model that showed the highest performance in the previous section. We first evaluated the performance using
the original Prior mammograms without image-to-image translation and later compared to the Prior
mammograms that were translated using the CycleGAN and Pix2Pix techniques.
Table 18a, 18b and 18c present results of early prediction on Prior mammograms that are reported
using the 5-fold cross validation as μ ± σ, where μ and σ refer to the mean and standard deviation,
respectively. We considered a true prediction where the location and type of breast lesions were correctly
captured using the inference model, retrospectively on non-cancerous screening views at t=0 years. The
inference evaluation was concluded using the ground-truth labels of the Current views that were generated
by experts later at t= [1, 6] years. Consequently, all predictions should be fairly compared to 0 predictions
(i.e., all were missed) by experts at t=0.
Table 18a: Inference results of YOLO Fusion model on Test sets of original Prior Mammograms

Breast Lesions

Results for Prior
Mammogram
Prediction
True prediction
μ±σ
Experts’ prediction
False prediction
μ±σ

Mass
33
22% ±
0.09
0
111
77% ±
0.08

Calcification

Inference

Architectural

Normal

Overall

image (sec)

Distortion

16

19

17% ± 0.07

31% ± 0.06

0

0

76

41

82% ± 0.16

68% ± 0.03

79

time per

26

94

81% ±

28% ±

0.02

0.06

0

0

6

234

18% ±

71% ±

0.17

0.03

0.62

Table 18b: Inference results of YOLO Fusion model on Test sets of Prior Mammograms using CycleGAN method

Breast Lesions

Results for Prior
Mammogram
Prediction
True prediction
μ±σ
Experts’ prediction
False prediction
μ±σ

Mass
32
22% ±
0.02
0
112
77% ±
0.07

Calcification

Inference

Architectural

Normal

Overall

image (sec)

Distortion

10

22

10% ± 0.08

36% ± 0.06

0

0

82

38

89% ± 0.03

63% ± 0.13

time per

26

91

81% ±

27% ±

0.02

0.07

0

0

6

237

18% ±

72% ±

0.07

0.02

0.63

Table 18c: Inference results of YOLO Fusion model on Test sets of Prior Mammograms using Pix2Pix method

Breast Lesions

Results for Prior
Mammogram
Prediction
True prediction
μ±σ
Experts’ prediction
False prediction
μ±σ

Mass
52
36% ±
0.01
0
92
63% ±
0.08

Calcification

Inference

Architectural

Normal

Overall

image (sec)

Distortion

13

30

14% ± 0.01

50% ± 0.02

0

0

79

30

85% ± 0.08

50% ± 0.01

time per

29

124

90% ±

37% ±

0.06

0.1

0

0

3

204

9% ±

62% ±

0.03

0.12

0.63

Results in Table 18a, 18b and 18c show the count and percentage of mammograms for each class
and overall, that were correctly predicted at Prior views and considered for an early detection and
classification. All true predictions presented two scenarios; one for all correct predictions on both Current
mammograms and their corresponding Prior views from the first exams (i.e., t=0), and another scenario for
only correct prediction on Prior mammograms even though their corresponding Current views were not
correctly predicted.
It is observed that the highest results were reported by the YOLO-based model that was inferred on
synthetic Prior mammograms by Pix2Pix technique, where a total number of 52 mammograms (36% ± 0.01)
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were accurately anticipated. We also noticed a high percentage of 36% ± 0.01 was shown for Mass lesions,
14% ± 0.01 for Calcification lesions, and 50% ± 0.02 for Architectural Distortion lesions. In addition, 90%
± 0.06 of Normal mammograms were accordingly classified on Prior exam screenings. The inference time
per each configuration was reported with a maximum value of 0.63 seconds per image.
Consequently, the Pix2Pix model indicates the most effective technique for image-to-image
translating mammograms from Prior to Current appearance to help increase the number of correct detection
and categorization of breast lesions at t=0. An overall true prediction rate of 37% was reported using the
proposed methodology that reveals the success of our suggested framework to help an early diagnosis without
the urgent need of a follow-up screening that might occur at a late stage for breast cancer.
We also reported the false prediction rate that counted the missed cases on Prior views by the inference
model. The reported numbers could be explained by the fact that we did not train the model on Prior views
as they were annotated by experts as being Normal at t=0.
Although the gold standard of the retrospective comparison we presented is 0 predictions at t=0, we
also noticed a drop of 9% on the false prediction using the synthetic Prior images that were generated by the
Pix2Pix model for image-to-image translation with an overall value of 62%.
Additionally, Figure 46 illustrates the confusion matrix for the classification of the true detected
bounding boxes on the Prior mammograms, where three types of lesions are presented with the Normal cases
(i.e., correct prediction without detected lesions). Prediction error for different classes is low with a maximum
rate of 3.5%.
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FIGURE 46: Confusion matrix of prediction results for Prior Mammograms

c. Retrospective analysis for the early detection and identification on prior
mammograms
In this part, we investigate the follow-up exam time (i.e., originally between 1 to 6 years) of the true
early prediction results for each class label. Figure 47 illustrates retrospectively that our suggested
methodology can anticipate the presence of breast lesions that were originally diagnosed at a later exam (i.e.,
t>0). Mass lesions were predicted beforehand but later detected by experts and radiologists within 2 to 3.5
years. The comparative figure also represents the latest follow-up exam time of results from using the imageto-image translation techniques versus the original mammograms.
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FIGURE 47: Comparison of Mean follow-up exam time for prediction results across classes with and without image-toimage translation Pix2pix and CycleGAN on Prior mammograms

Moreover, Figure 48 illustrates a comparison of inference results of the YOLO-based model with
and without image-to-image translation across the different classes and overall. We can visually conclude
that the Pix2Pix translation method had the best performance, which could also be explained by the fact the
Pix2Pix model was trained between paired images, compared to the CycleGAN model that used unpaired
images. Hence, the Pix2Pix model is more efficient than the CycleGAN for the task of image-to-image
translation considering the advantage of image alignment it presents between the paired datasets.
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FIGURE 48: Comparison performance of YOLO Fusion model across classes with and without image-to-image
translation

Furthermore, we compared results of the early detection and classification across the Prior exam’s
time that varied between 1 to 6 years. Figure 49 provides a visual observation of the percentage of correctly
predicted Prior mammograms for each class label using the best-reported experiment (i.e., using the Pix2Pix
translation). The follow-up exam time of 1 year had the highest rate of predicted images. This emphasizes
the success of our methodology to early localizing and identifying lesions that are often considered the
hardest to diagnose. Another observation is that our methodology captured the Mass lesions that had followup requests of later than 3 years, which might be too late to diagnose patients with Mass breast lesions.

FIGURE 49: Comparison performance of YOLO Fusion model and Pix2Pix for image-to-image translation for different
classes across follow-up exam time (years)

Finally, two samples of mammograms that were taken from different patients, including Prior exam
views and their corresponding Current exam views are shown below in Figure 50. Two cases of results are
demonstrated: 1) When both Current and Prior mammograms were correctly predicted, and 2) When only
the Prior mammograms were correctly predicted. It seems that when the model failed to predict lesions in
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some Current mammograms, their corresponding Prior mammograms were successfully predicted using the
inference model. Predicted bounding boxes were slightly different between views but they exceeded the
threshold score, and this could be explained with the different quality of the acquired images and the type of
the detected lesions. Moreover, Normal mammograms were shown in the last row accordingly where correct
predictions were demonstrated for both screening and for only Predicted mammograms.
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Figure 50: Example results on Prior mammograms vs Current mammograms using the YOLO-based Fusion model that
was inferred on the translated Prior images from Pix2Pix method across classes: Mass (red bounding boxes, first row),
Calcification (green bounding boxes, second row), and Architectural Distortion (yellow bounding boxes, third row). Red
arrows point to the ground truth location. Last row belongs to the Normal class

Finally, a comparison of latest studies and similar methods were reported against our proposed
methodology. For a complete and fair comparison, only works that were applied for Mass lesions detection
were reported and compared in Table 19. Comparing both detection accuracy rate and inference time with
the other works that were evaluated on the two public datasets CBIS-DDSM and INbreast, our YOLO-based
fusion models achieved overall better than previous works. Our recent work was considered having the best
trade-off between the detection accuracy and testing time comparing to the work by Peng et al. [61] that had
a better inference time of 0.134 second per image but it only had a detection accuracy rate of 93.45% on the
CBIS-DDSM dataset. Accordingly, the work by Al-Antari et al. [63] had faster inference time of 0.025
seconds per image on Mass detection for the INbreast dataset, but our results exceeded their detection
accuracy rate of only 97.27%. Additionally, it is fair to mention that all experiments in the related works were
conducted using different configurations and preprocessing techniques, which may show different
performance on public datasets. We also compared the work of Zheng et al. [152] that similarly conducted
the detection and classification tasks on the UCHCDM dataset. Although the surveyed work achieved a better
overall performance of 92.8% than our reported results, the tasks were not simultaneous and required separate
inference time of 0.62 seconds per image for the detection method and 0.88 seconds per image on the
classification.
The framework of the retrospective analysis of YOLO-based fusion model prediction on prior
mammograms was recently published in the Computer Methods and Programs in Biomedicine Journal [190].
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Table 19: Comparison of Mass detection with other works

Reference

Al-masni et al.
[68]
Dhungel et al.
[167]
Al-masni et al.
[49]

Year

2017

2017

2018

Method

Detection

Inference time

accuracy rate

per image

(%)

(sec))

DDSM

85.25

NA

INbreast

96

39

DDSM

99.7

NA

UCHCDM

92.8

Dataset

YOLO
Cascade Deep Learning
and Random Forest
YOLO
Detection: 3 cascading

Zheng et al [81]

2018

detectors (Haar, LBP, and
HOG)
Classification: VGG-19

Agarwal et al.
[32]
Aly, G. et al.
[52]

2019

2020

0.88

CNN patch classifier and

CBIS-

mass probability map

DDSM

(MPM)

INbreast

98

YOLO

INbreast

89.5

CBISPeng et al. [61]

Al-Antari et al.
[63]
Singh et al. [89]

2020

2020

2020

DDSM

Faster R-CNN

YOLO
Single Shot Detector
(SSD)

Proposed

82
NA

0.009

93.45
0.134

INbreast

95.54

INbreast

97.27

0.025

INbreast

97

NA

95.7

0.55

CBIS2021

0.62

YOLO-based Fusion

DDSM

Models

INbreast

98.1

0.58

INCAN

98

0.52

UCHCDM

92.09

0.62

Methodology
YOLO-based Fusion
2022

Models
(Current mammograms)

Furthermore, we compared the effort of similar works on conducting an early detection of breast
lesions against our work contribution. Table 20 shows two recent works that had the closest similarity on
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integrating Prior mammograms views to predict the location and type of abnormal lesions. Our work
surpassed the work of Watanabe et al. [168] that was able to accurately detect and distinguish Mass lesions
with an early detection accuracy rate of 27%. However, our proposed methodology had a lower early
detection accuracy rate on Calcification lesions where they had 20% on a custom dataset that was generated
using the temporal subtraction technique. Genuinely, all the reviewed works were assessed on private datasets
and the reported results could be distinctive compared to our study’s outcome. All comparable works did not
measure the testing time, but our proposed method achieved an inference time of only 0.63 seconds per
image.
Table 20: Comparison of Early detection with other works

Early
Reference

Year

Method

Dataset

Class Label

Detection
accuracy
rate (%)

Watanabe et
al. [76]

Inference
time per
image (sec)

cmAssist –
2019

Custom deep

Private

Mass

27

NA

Custom

Calcification

20

NA

Mass

36 ± 0.01
14 ± 0.01

learning networks

Loizidou et al.
[79]

2019

Temporal
subtraction
YOLO-based

Proposed
Methodology

2022

Fusion Models +

UCHCDM

Calcification

Pix2Pix

+

Architectural

translation

Synthetic

Distortion

(Prior

dataset

Normal

90 ± 0.06

Overall

37 ± 0.10

mammograms)

50 ± 0.02

0.63

3. Breast Mass Segmentation
a. Quantitative segmentation results
As shown in Table 21, the results are measured for each testing set where we computed the twoevaluation metrics for the segmented maps per pixel and compared them to the original ground truth.
Table 21: Segmentation performance of our proposed networks on the test sets
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Proposed
Architectures

Dice score

IoU score

Dice score

IoU score

Dice score

IoU score

(%)

(%)

(%)

(%)

(%)

(%)

CBIS-DDSM

INbreast

INCAN

Standard UNet

78.62

64.87

89.21

79.5

89.87

86.43

Connected-UNets

82.22

69.82

93.36

85.75

95.72

91.95

Standard AUNet

80.39

67.29

91.35

82.59

90.25

88.02

Connected-AUNets

83.84

72.19

93.52

86.01

95.82

92.17

Standard ResUNet

80.94

68.05

92.71

84.58

93.58

89.79

85.01

73.95

94.13

87.63

95.88

92.27

ConnectedResUNets

The results reveal that the proposed Connected-UNets architecture outperforms the regular UNet in
terms of Dice and IoU scores across all experimental datasets. We also enhanced the segmentation
performance of the standard AUNet and ResUNet using the architecture. As a result, the results reveal a
comparison of the conventional architectures, with ResUNet outperforming the AUNet and the later
architecture outperforming the UNet. The findings highlight the benefits of the attention mechanism as well
as the residual blocks added to the simple UNet. We clearly notice an improvement of Dice score by 3.6%
using the Connected-UNets, 3.4% using the Connected-AUNets, and 4% using the Connected-ResUNets on
the CBIS-DDSM dataset. With the Connected-UNets, we enhanced the Dice score by 4.15 %, 2.17 % with
the Connected-AUNets, and 1.42 % with the Connected-ResUNets for the INbreast dataset. Similarly, we
had an improvement of Dice score on the INCAN private dataset by 5.85% using the Connected-UNets,
5.57% using the Connected-AUNets, and 2.3% using the Connected-ResUNets.
Furthermore, the area under curve (AUC) over test sets of all datasets was used to evaluate the
segmentation performance of our proposed Connected-UNets and its modifications against the conventional
UNet, AUNet, and ResUNet. Each model was used to create segmented images with pixels estimated to be
between 0 and 255. The anticipated images were then normalized using scores between 0 and 1. Ground truth
images were similarly adjusted to have values of 0 or 1. As a result, the problem was turned into a binary
pixel classification task, and the receiver operating characteristic (ROC) between the predicted pixels and
their true values was calculated. Figure 51 shows a comparison of ROC curves where we clearly notice that
the proposed architectures outperform all standard models with an average AUC of 0.79 for the CBIS-DDSM,
0.94 for the INbreast, and 0.95 for the INCAN private dataset.
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FIGURE 51: Performance of mass segmentation using the different architectures in terms of ROC curves on the test sets
of CBIS-DDSM, INbreast, and the INCAN private datasets
ROC curve plots with True positive Rate (TPR) against the False Positive Rate (FPR) and area under curve for pixelwise evaluation of the standard models (UNet, AUNet, and ResUNet) and for the proposed architecture models
(Connected-UNets, Connected-AUNets, and Connected-ResUNets).

According to Table 21, the INCAN private dataset had the best segmentation performance along
with the proposed architectures as it represents the best image resolution among the used mammography
datasets. Therefore, we applied the CycleGAN model to translate images from CBIS-DDSM and INbreast
datasets (i.e., weak domains) into the INCAN private dataset (i.e., strong domain). After training the
CycleGAN model between the unpaired datasets and producing new ROI masses for the CBIS-DDSM and
the INbreast, synthetic pictures were constructed, as demonstrated in the examples below in Figure 52, where
we clearly see the enhanced quality of the new ROI masses that benefit from each dataset’s texture.
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FIGURE 52: Samples of synthetic data from CBIS-DDSM and INbreast datasets generated by CycleGAN model using
the INCAN private dataset.

Furthermore, we trained the proposed architectures on the original and synthetic images to predict
the segmentation mappings. Table 22 shows the improvement of segmentation’s performance of all the
standard and architectures using the joined dataset of original and synthetic images. In fact, we notice an
increase of Dice score on the CBIS-DDSM by 3.76% using the standard UNet, 3.97% using the standard
AUNet, and 4.17% using the ResUNet. Similarly, we have an improved Dice score of 4.8% using the
Connected-UNets, 4.11% using the Connected-AUNets, and 4.51% using the Connected-ResUNets.
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Table 22: Comparison of the proposed architectures after adding synthetic CBIS-DDSM and INbreast

Proposed
Architectures

Standard UNet
ConnectedUNets
Standard
AUNet
ConnectedAUNets
Standard
ResUNet
ConnectedResUNets

Dice

IoU

Dice

IoU

Dice

IoU

Dice

IoU

score

score

score

score

score

score

score

score

(%)

(%)

(%)

(%)

(%)

(%)

(%)

(%)

CBIS-DDSM

CBIS-DDSM with

INbreast

INbreast with

without Synthetic

Synthetic data

without

Synthetic data

data

(CycleGAN)

Synthetic data

(CycleGAN)

78.62

64.87

82.38

72.59

89.21

79.5

93.45

87.54

82.22

69.82

87.02

77.07

93.36

85.75

95.16

90.77

80.39

67.29

84.36

74.02

91.35

82.59

94.73

89.99

83.84

72.19

87.95

78.89

93.52

86.01

94.89

90.28

80.94

68.05

85.11

76.13

92.71

84.58

94.48

89.59

85.01

73.95

89.52

80.02

94.13

87.63

95.28

91.03

Finally, all the suggested models are used to evaluate the integrated framework. As the end-to-end
performance depends on the first detection and localization step which used the YOLO model, the
segmentation step was first reported using the segmentation accuracy measure IoU90 score that was later
multiplied by the detection accuracy rate to form a final segmentation accuracy. Table 23 shows a comparison
of final segmentation results of the different models after using the detection accuracy rate of 95.7%, 98.1%,
and 98%, respectively, for CBIS-DDSM, INbreast, and the INCAN private dataset. Consequently, we
reported a final segmentation performance with a maximum accuracy of 86.91%, 93.03%, and 95.39% using
the Connected-ResUNets architecture model, respectively, for CBIS-DDSM, INbreast, and the INCAN
private dataset.
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Table 23: Final Segmentation performance of our proposed networks on the test sets

IoU90

Final

IoU90

Final

IoU90

Final

Proposed

score

Segmentation

score

Segmentation

score

Segmentation

Architectures

(%)

accuracy (%)

(%)

accuracy (%)

(%)

accuracy (%)

CBIS-DDSM

INbreast

INCAN

Connected-UNets

90.05

86.18

94.06

92.27

96.99

95.05

Connected-AUNets

90.24

86.36

94.63

92.83

97.22

95.27

Connected-ResUNets

90.82

86.91

94.83

93.03

97.34

95.39

Finally, a comparison of the results of the latest state-of-the-art methods and models to segment the
breast masses is listed in Table 24. Our proposed architectures outperformed the UNet model and its current
variations. On the two public datasets, we achieved the best segmentation performance using the designs
when comparing the Dice and IoU scores to the other methods: CBIS-DDSM with a Dice score of 89.52%
and an IoU score of 80.02%, and INbreast with a Dice score of 95.28% and an IoU score of 91.03% using
the Connected-ResUNets. We outperformed Ravitha Rajalakshmi et al. [53] by 6.62% Dice score on the
CBIS-DDSM dataset, and the work of Li et al.32 by 2.56% Dice score on the INbreast dataset.
The integrated framework of the new Connected-UNets architecture model and the previous YOLObased fusion model was published in the Nature Partner Journal – Breast Cancer [176].
Table 24: Comparison of the proposed architectures and state-of-the-art methods

Reference

Year

Dhungel et al. [76]

2015

Dhungel et al. [135]

2017

Zhu et al. [88]

2018

Dice score

IoU score

(%)

(%)

INbreast

85

--

CNN + CRF

INbreast

90.06

--

Multi-scale FCN-CRF

INbreast

90.97

--

INbreast

92.63

86.37

INbreast

92.72

--

Method
Deep structured output
learning + refinement

Dataset

Fully resolution
Al-Antari et al. [62]

2018

Convolutional Network
(FrCN)
Conditional Residual

Li et al. [96]

2018

Wang et al. [103]

2019

ResNet34 + ASPP

INbreast

91.1

--

Abdelhafiz et al. [94]

2019

R-UNet

INbreast

90.5

89.1

Sun et al. [100]

2020

Attention UNet

INbreast

79.1

--

UNet
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Ravitha Rajalakshmi et
al. [101]

2020

CBIS-DDSM

81.8

--

Deeply supervised U-Net

INbreast

79

83.2

(DS U-Net)

CBIS-DDSM

82.9

--

Singh et al. [89]

2020

conditional GAN (cGAN)

INbreast

91.47

83.58

Tsochatzidis et al. [105]

2021

UNet+

CBIS-DDSM

72.2

56.5

INbreast

95.16

90.77

CBIS-DDSM

87.02

77.07

INbreast

94.89

90.28

CBIS-DDSM

87.95

78.89

INbreast

95.28

91.03

CBIS-DDSM

89.52

80.02

Connected-UNets

Proposed architectures

2021

Connected-AUNets

Connected-ResUNets

b. Qualitative segmentation results
We performed a post-processing step on all segmented ROI masses by simply eliminating any
outlier points that were too far away from the lesions' primary contour. As a result, we took all the possible
contours from the binary masks and only chose the one with the greatest area. The output of the conventional
UNet models, the Connected-UNets model, and their variants were subjected to this.
Figure 53 shows examples of the segmented ROI masses generated by the experimental models
against their ground truth images. We can plainly see that the Connected-UNets segmentation maps and
outcomes are of varying quality, and that their variations always contain less error and capture more precision
than the ground truth. We can see from the segmentation results that Connected-ResUNets is better than the
other designs at predicting the smallest aspects of the tumor's boundaries.
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FIGURE 53 Examples of the segmentation results on the test set of the datasets. Subplot on the top shows two samples
of mammograms from the CBIS-DDSM dataset.

Overall, the proposed architectures outperform the typical architectures, demonstrating their ability
to learn complicated features thanks to the connections made between the two UNets in the proposed
Connected-UNets, which uses decoded features as an additional input in the encoder route.
As a result, Figure 54 shows a visual comparison of the Connected-ResUNets model, which uses
the recommended ASPP block to connect each encoder and decoder, against the same model without the
ASPP block. We can conclude that the ASPP block improved the segmentation results' precision.
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FIGURE 54: Examples of the segmentation results for the proposed architecture Connected-ResUNets comparing with
and without using ASPP block.

After that, a qualitative segmentation comparison of the proposed Connected-ResUNets against the
basic ResUNet architecture is presented in Figure 55. In addition, for each associated ROI mass, a comparison
of Dice and IoU scores is made. We found that the proposed architecture model can capture the tiniest
characteristics of tumors of all forms and sizes across all datasets. As a result, it is obvious that the ConnectedResUNets predicted contours are the most like the ground truth contours, as seen by the greatest Dice and
IoU score values. After adding the synthetic images created by the CycleGAN model to the training data, we
compared the segmentation results of one of the recommended architecture models, Connected-ResUNets.
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FIGURE 55: Examples of the segmented masses for the proposed architecture Connected-ResUNets comparing with the
ResUNet

Figure 56 shows a better segmented contour of the mass tumor using the additional synthetic images.
The new training data produces more exact pixel segmentation that closely resembles the ground truth
images. As a result, the quality of the segmentation findings demonstrates the benefit of using synthetic
images to improve segmentation quality, as well as the capacity of cross-modality synthesis to increase data
quantity and improve quality by incorporating additional related domains. Finally, we applied two state-ofthe-art methods that we discussed, by Al-Antari et al. [22] and Li et al. [32], to segment ROIs from all the
mammography datasets, and visual comparison shows that predictions of two suggested models FrCN and
CRUNET are slightly close to the ground truth images but they do not represent the contours exactly.
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FIGURE 56: Examples of the segmentation results for the proposed architecture Connected-ResUNets with and without
adding the synthetic data

Examples shown in Figure 57 are selected to be challenging for segmentation and our proposed
architecture models showed better visual results to segment the mass lesions.

FIGURE 57: Examples of the segmentation results for the proposed architecture models again two state-of-the-art
methods FrCN and CRUNET
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4. Classification and Diagnosis
a. Quantitative classification results
The proposed breast mass classification model was trained and compared to single base models for
each presented task on the different mammography datasets. We also compared the stacked ensemble of
models to a conventional average of different models’ weights with an XGBoost classifier.

i. Pathology classification
As shown in Table 25a, Table 25b, and Table 25c, the pathology classification results are compared
between different models respectively for CBIS-DDSM, INbreast, and INCAN private datasets. It is
reasonable to mention that because the INCAN private dataset includes only malignant cases, we trained and
tested the model on a combination of all datasets.
Table 25a: Pathology classification results on the CBIS-DDSM dataset

F1-

Model

Accuracy

Sensitivity

Specificity

Model1: ResNet50V2

89.97

0.89

0.91

0.9

0.9

Model2: ResNet101V2

93.57

0.92

0.95

0.94

0.93

Model3: ResNet152V2

92.11

0.92

0.92

0.92

0.92

91.04

0.85

0.98

0.91

0.91

95.13

0.93

0.97

0.95

0.95

Average Weights of Model1, Model2 and
Model3 + XGBoost Classifier
Stacked Ensemble of models

score

AUC

Table 25b: Pathology classification results on the INbreast dataset

F1-

Model

Accuracy

Sensitivity

Specificity

Model1: ResNet50V2

98.52

1.0

0.93

0.97

0.96

Model2: ResNet101V2

95.58

1.0

0.80

0.93

0.9

Model3: ResNet152V2

96.6

1.0

0.90

0.91

0.94

97.9

1.0

0.96

0.98

0.97

99.2

1.0

0.98

0.99

0.99

Average Weights of Model1, Model2 and
Model3 + XGBoost Classifier
Stacked Ensemble of models
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score

AUC

Table 25c: Pathology classification results on the INCAN private dataset

F1-

Model

Accuracy

Sensitivity

Specificity

Model1: ResNet50V2

92.83

0.94

0.90

0.91

0.92

Model2: ResNet101V2

94.18

0.94

0.95

0.93

0.94

Model3: ResNet152V2

94.60

0.94

0.94

0.94

0.94

94.89

0.94

0.97

0.93

0.94

95.88

0.93

0.97

0.95

0.96

Average Weights of Model1, Model2 and
Model3 + XGBoost Classifier
Stacked Ensemble of models

score

AUC

The comparative results show that the proposed stacked ensemble of models performs better than
the base ResNet models having different numbers of deep layers (i.e., ResNet50V2, ResNet101V2 and
ResNet152V2). Accordingly, our proposed methodology outperformed the average ensemble of models with
an XGBoost classifier that performed slightly better than individual models. We clearly notice a high
accuracy of 95.13% on the CBIS-DDSM dataset, 99.2% on the INbreast dataset, and 95.88% on the INCAN
private dataset. Besides, our proposed model achieved a high sensitivity rate of 0.93 on the CBIS-DDSM
dataset, 1.0 on the INbreast dataset, and 0.93 on the INCAN private dataset. Consequently, the results
emphasize generally the advantage of ensemble learning technique on improving the classification
performance, and particularly the improvement achieved by the stacking method using deep learning models.
Moreover, the pathology classification performance was compared against the different models
using the AUC over the test sets of all datasets. Figure 58 shows plots of the Receiver Operating
Characteristic (ROC) curves of the True positive Rate (TPR) against the False Positive Rate (FPR), and we
clearly notice that the proposed model outperformed all experimental techniques with an AUC of 0.95 for
the CBIS-DDSM dataset, 0.99 for the INbreast dataset, and 0.96 for the INCAN private dataset.
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FIGURE 58: Performance of pathology classification using different models in terms of ROC curves and AUC score

ii. BI-RADS category classification
Results shown in Table 26a, Table 26b and Table 26c for BI-RADS category classification illustrate
the comparison between different models for all mammography datasets. As mentioned in the section on
Datasets description, each dataset has different class labels that vary from category 2 to category 6.
Table 26a: BI-RADS category classification results on the CBIS-DDSM dataset

Model

Accuracy

AUC

Model1: ResNet50V2

80.07

0.93

Model2: ResNet101V2

77.12

0.92

Model3: ResNet152V2

80.08

0.93

79.48

0.85

83.84

0.94

Average Weights of Model1, Model2 and
Model3 + XGBoost Classifier
Stacked Ensemble of models
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Table 26b: BI-RADS category classification results on the INbreast dataset

Model

Accuracy

AUC

Model1: ResNet50V2

98.0

0.94

Model2: ResNet101V2

98.0

0.97

Model3: ResNet152V2

96.1

0.92

97.1

0.99

99.0

1.00

Average Weights of Model1, Model2 and
Model3 + XGBoost Classifier
Stacked Ensemble of models

Table 26c: BI-RADS category classification results on the INCAN private dataset

Model

Accuracy

AUC

Model1: ResNet50V2

91.91

0.91

Model2: ResNet101V2

92.43

0.92

Model3: ResNet152V2

94.25

0.94

92.95

0.93

96.08

0.95

Average Weights of Model1, Model2 and
Model3 + XGBoost Classifier
Stacked Ensemble of models

The classification results presented above demonstrate a clear improvement of the performance
using our proposed stacked ensemble of models comparing to the basic models with an accuracy of at least
3.78% on the CBIS-DDSM dataset, 1% on the INbreast dataset, and 1.83% on the INCAN private dataset.
Moreover, our methodology achieved a better AUC score than the average ensemble model with an XGBoost
classifier where we notice a high AUC of 0.94 for the CBIS-DDSM dataset, 1.00 on the INbreast dataset,
and 0.95% on the INCAN private dataset. This can be confirmed with a visual comparison of ROC curve
plots between employed models as illustrated in Figure 59.
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FIGURE 59: Performance of BI-RADS category classification using different models in terms of ROC curves and AUC
score

iii. Shape classification
Lastly, the proposed model was trained on the CBIS-DDSM dataset for classifying the shape of
breast masses, as it is the only dataset that possesses shape annotation by experts. Equivalently, all trained
models were tested, and comparison is shown in Table 27. Undoubtedly, our suggested stacked ensemble of
models had the highest accuracy score of 90.02% among the employed models, which improved the
performance of separate models notably with 1.7% and remarkably with 10.66% compared to the average
ensemble of models with an XGBoost classifier.
Table 27: Shape classification results on the CBIS-DDSM dataset

Model

Accuracy

AUC

Model1: ResNet50V2

75.51

0.90

Model2: ResNet101V2

89.90

0.95

Model3: ResNet152V2

88.32

0.97

79.36

0.84

90.02

0.98

Average Weights of Model1, Model2 and
Model3 + XGBoost Classifier
Stacked Ensemble of models
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Furthermore, Figure 60 presents a comparison of ROC curve plots for the different employed models
and represents the AUC score accordingly. We clearly notice that our proposed model had the highest AUC
of 0.98 among the presented models, which was close to the ResNet152V2 performance but with a slightly
better accuracy rate.

FIGURE 60: Performance of Shape classification using different models in terms of ROC curves and AUC score

b. Qualitative classification results
Previous comparison results highlighted that our proposed methodology yielded the best results for
the different classification tasks. Consequently, we analyzed the classification prediction between different
datasets using the confusion matrix that summarizes the results across the class labels.
Figure 61, Figure 62, and Figure 63 respectively present the normalized confusion matrix plots for
each classification problem. As indicated below, the INbreast dataset had the best pathology classification
tradeoff between malignant and benign classes, and this can be explained with the high-quality resolution of
the mammograms collected in FFDM format that helps distinguish between the two class labels. The INCAN
private dataset had also a remarkable confusion matrix with close recall and precision scores, which were
like the CBIS-DDSM dataset’s performance.
Moreover, the INbreast dataset had the best BI-RADS categorization tradeoff with a notable
prediction per class from 0.92 to 1.0. Concerning the INCAN private dataset, it has only two BI-RADS
categories 4 and 5, and we notice a similar satisfying confusion matrix with prediction scores of 0.93 and
0.96. The CBIS-DDSM dataset has a slightly worse tradeoff for the BI-RADS category classification, and
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this is due to the low resolution of deteriorated ROI images from the digitized X-rays mammograms. In fact,
the confusion matrix shows values from 0.80 to 0.89 and we clearly notice that the four categories have a
close prediction score due to the similarity of the pixel distribution caused by the quality presented in the
public dataset.
Finally, the confusion matrix for the shape classification showed an overall sufficient tradeoff
between the class labels. We clearly observe similar predicted results for the irregular and lobulated cases
with a maximum value of 0.93, and this can be interpreted by the close appearance of the two lesions’ shape.
However, oval, and round cases had worse results, and in particular, the round class label had a performance
score of 0.73.

FIGURE 61: Confusion matrix of the stacked ensemble of models for the pathology classification on the mammography
datasets

FIGURE 62: Confusion matrix of the stacked ensemble of models for the BI-RADS category classification on the
mammography datasets
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FIGURE 63: Confusion matrix of the stacked ensemble of models for the Shape classification on the datasets

Additionally, we reported the classification results of the final integrated CAD system using the
segmentation step and compared it to results of the proposed method without using the segmented ROIs.
Table 28 shows a better classification performance for each task on all mammography datasets, where the
pathology classification demonstrated improvement of 4.26% on the CBIS-DDSM dataset, 4% on the
INbreast dataset, and 5.5% on the INCAN private dataset. Accordingly, the BI-RADS category classification
presented enhanced performance using the detected and segmented images with accuracy difference of 3.69%
on the CBIS-DDSM dataset, 1.5% on the INbreast dataset, and 0.38% on the INCAN private dataset. Finally,
the CBIS-DDSM dataset had improved the shape classification results with 4.36% accuracy. Consequently,
it is clearly observed that the CAD system with the integrated detection and segmentation stages achieved
much better results for the classification and diagnosis of breast masses.
Table 28: Comparison of classification performance (accuracy %) using the proposed CAD system with and without
mass segmentation

Pathology

BI-RADS Category

Shape

CAD system

CAD system

CAD system

CAD system

CAD system

CAD system

without mass

with mass

without mass

with mass

without mass

with mass

segmentation

segmentation

segmentation

segmentation

90.87

95.13

81.69

85.38

85.66

90.02

INbreast

95.20

99.20

97.50

99

NA

NA

INCAN

90.38

95.88

95.70

96.08

NA

NA

Dataset

CBISDDSM
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segmentation segmentation

Finally, a comparison of results of the latest state-of-the-art methods and similar models to classify
the breast masses is listed in Table 29. Our proposed CAD system that integrates the previous detection and
segmentation steps and the current proposed classification framework outperformed the previous deep
learning models applied for pathology, BI-RADS category, and shape classification. Compared with other
techniques that used segmented ROIs, we exceeded the performance of the work by Falconí et al. [127] that
only achieved an accuracy of 78.4% using the MobileNet model on the CBIS-DDSM dataset. On the other
hand, we also outperformed the work of Alkhaleefah et al. [128] even though they did not use segmented
input images and reported an accuracy of 93.47%. Moreover, recent works on the INbreast dataset were all
surpassed where the highest accuracy of 98.26% was reported by Chakravarthy et al. [124] using the ICSELM algorithm on original ROI masses. We also reported better accuracy score for the pathology
classification applied on segmented ROIs from the INbreast dataset, where Al-Antari et al. [62] only achieved
an accuracy of 95.64% and an AUC score of 0.94. The results of the BI-RADS categorization also
outperformed the previous works on CBIS-DDSM dataset with the work suggested by Medeiros et al. [130]
that applied DenseNet201 on original ROI masses and only achieved an accuracy of 63.4%. No previous
work applied the BI-RADS category classification on segmented images and therefore we could not compare
with our proposed work. Accordingly, our method surpassed the performance on the INbreast dataset by the
work of Falconí et al. [129] that only reported an accuracy of 90.9% using NasNet and VGG models. Lastly,
our methodology gained the best shape classification performance compared to a recent work of Singh et al.
[89] that applied a CNN model on a similar dataset, and it is reasonable to say that this reviewed work is the
only comparable work that applied shape classification on detected and segmented ROIs but only achieved
an accuracy of 80%.
The entire integrated framework of the Stacked Ensemble of Residual neural networks model and
the previous Connected-UNets architecture model and the YOLO-based fusion model was submitted to the
Scientific Reports Journal, and it is currently under revision [177].
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Table 29: Comparison of the proposed methodology and state-of-the-art methods

Reference

Year

Method

Classification

Dataset

Pathology

INbreast

Pathology

INbreast

Segmented

Accuracy

AUC

Yes

--

0.80

Yes

95.64

0.94

Yes

78.4

--

No

84.4

0.84

No

98.26

--

No

93.47

0.97

No

63.4

--

Images

multi-view
Dhungel et al.
[135]

2017

deep residual
neural network
(mResNet)

Al-Antari et
al. [62]

Falconí et al.
[127]
Falconí et al.
[178]

Ensemble of
2018

AlexNet-based
CNN
MobileNet and

2019

NasNet + fine

Pathology

tuning
2020

VGG16 + fine
tuning

Pathology

CBISDDSM
CBISDDSM

Improved
Crow-Search
Optimized
Chakravarthy
et al. [124]

2020

Extreme
Learning

Pathology

INbreast

Machine (ICSELM)
algorithm
AlexNet, VGG,
Alkhaleefah
et al. [128]

2020

GoogLeNet,
ResNet

Pathology

CBISDDSM

+ fine tuning
Medeiros et al
[130]

2020

DenseNet201 +
MLP

BI-RADS

CBISDDSM

NasNet + fine
Falconí et al.
[129]

2020

tuning on
VGG16 and

BI-RADS

INbreast

No

90.9

0.99

Shape

DDSM

Yes

80

0.80

Pathology

INbreast

Yes

--

0.93

VGG19
Singh et al.
[89]
Li et al. [133]

2020

2021

CNN
DualCoreNet:
Texture and
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shape features
fusion
CBISPathology

Proposed
Methodology

INbreast

Yes

INCAN
Stacked
2022

DDSM

CBIS-

Ensemble of
ResNet models

BI-RADS

DDSM
INbreast

Yes

INCAN
Shape

CBISDDSM

Yes

95.13

0.95

99.20

0.99

95.88

0.95

85.38

0.94

99

1.00

96.08

0.95

90.02

0.98

E. Testing & Deployment
The entire connected framework we suggested for the CAD system of breast cancer diagnosis was
deployed on a server to showcase the performance and results of the experimental tool. To deploy the
developed tool that is based on several deep learning architecture models, all the trained models’ weights and
biases were saved for inference. Because of the large number of parameters and weights matrix in each model,
we tried first to lightweight the saved models before being used in the final implementation. To do that, we
applied a post-training quantization technique to the models we saved in Keras framework [179, 180].
Therefore, we optimized the deployment of our CAD tool by reducing the size of the entire model while
maintaining the performance and accuracy.
During the training and validation stages, we relied on a GPU and large storage to learn the large
models where each model was worth at least 3 GB. However, during the deployment, the server may accept
the size of the inferred models, but it would not respond fast. Consequently, the tool will perform expensive
computations and generate late results.
We applied the post-training optimization technique that reduces the CPU and hardware accelerator
latency and processing and optimized the model size with quite a drop in performance [181]. The technique
applies to convert the already-trained Tensorflow models into Tensorflow Lite models. As a result, the
models were saved into TFLite format files that will be placed within the backend package for the
deployment. In fact, the files’ sizes have been reduced to 75% using the quantized models.
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We initially tested the integrated CAD system offline to evaluate the TFLite conversion by building
a script that calls and executes the three main steps in the order of the suggested logic. As we discussed in
the previous chapters, the output of one-step should serve as an input of the next step, and the integrated
framework should be starting from an entire mammogram to yield the final diagnosis prediction results that
include the pathology, the BI-RADS assessment score, and the shape.
Before applying the model quantization to the deployment, the offline testing took around 6 minutes
per image to execute the whole system, which is unfortunately slow. However, after using the post-training
dynamic range optimization, the testing time changed to less than 1 minute per image thanks to the
lightweight models.
After preparing the backend package, we implemented the design of web service that was developed
using JavaScript and React library. As shown in in Figure 64, the web server should process users’ requests
by just allowing them uploading mammography images, in either DICOM format or image format (i.e. .png,
.jpg, etc.). After that, the system accepts the images and assigns a corresponding transaction code to the user
to start the processing.
Next, the backend script should sequentially execute an image, first return the detected ROI, and
then identify if it is Mass lesion where the detected ROI box is also highlighted on the entire mammogram.
Second, the system should generate the segmented image of the detected ROI, and finally return the three
classification and diagnosis. As soon as the system is ready to return the results, the code assigned to the
user should be used to check the results and send an e-mail to notify the user with the results.

FIGURE 64: Framework of the deployed CAD system
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F. Discussion
In this dissertation, we have designed implemented an integrated CAD system using deep learning
models for detection and identifying abnormal lesions in mammograms, segment and mask the background
of masses, and classifying their pathology and final diagnosis.
In the first step, we have implemented a deep learning YOLO model to simultaneously detect and
classify the suspicious lesions in the breast. Similar studies focused solely on the identification of mass
lesions and the extraction of areas of interest for further diagnosis. In contrast, our study expands the ability
of YOLO-based model to conduct simultaneous detection and classification on mammograms [49].
Furthermore, the presented approach revealed the advantage of YOLO model as detector and
classifier toward different clinical mammographic images (i.e., digitized X-rays, full-field digital
mammography, etc.). The resilience of YOLO to correctly identify breast lesions above pectoral muscle, near
to breast nipples, or over thick tissues is also demonstrated by the quality of anticipated pictures, as illustrated
in Figure 41. Experimental results showed that training YOLO-based deep learning model is overall fast and
accurate, where our results outperform the SSD method [89], the Faster R-CNN model [63], the CNN model
[32] and other machine learning techniques [31, 167] that had a maximum detection accuracy rate of 98% on
INbreast dataset but a significantly high inference time. The comparison revealed that YOLO model is the
right choice for mass detection in mammography as presented in other existing YOLO implementations [52,
632, 63] with a maximum detection accuracy rate of 97.27% on INbreast dataset, and our study enhanced the
state-of-the-art results to be 98.1%. However, the suggested YOLO model has constraints in the training
configuration, which is dependent on creating the correct format of input data. Thus, input images should be
accompanied by the true locations and class labels of the lesions during the training. As a result, the YOLO
model has an input dependency since the locations of lesions must be extracted from the ground truth.
In the second step, we introduced a novel architecture, called Connected-UNets, which fully
connects two single UNets using additional skip connection paths. The ASPP mechanism is also used by the
network as a transition block to address the problem of resolution loss, which is particularly problematic in
the case of small tumors. The proposed mass segmentation architecture expands the ability of skip
connections to reconstruct the details lost in the encoding pathway by revoking the first decoded features and
connect them with the additional encoded inputs. The design was implemented on two UNet variants: the
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Attention UNet (AUNet) and the Residual UNet (ResUNet). The results of the proposed architectures showed
the segmentation improvement compared to the basic architectures as shown in Table 21 with a maximum
Dice score of 89.52% on the CBISDDSM dataset and 95.28% on the INbreast dataset. Furthermore, the
quantitative examination revealed that ResUNet and AUNet had an edge in segmenting bulk tumors. Hence,
the improved architectures’ Connected-AUNets and Connected-ResUNets outperformed the ConnectedUNets in all the used mammography datasets. Comparison of the segmentation map results of each model
approve the enhancement made to the standard models to provide a precise segmentation of the mass
boundaries as shown in Figure 52. Limitations of the proposed architectures can occur on the long training
time of an average of 0.638 s per epoch, which is due to the high computation of the neural networks that
have more trainable parameters than the standard architecture models.
Finally, in the last step, we have implemented a stacked ensemble of ResNet models to classify
breast masses as malignant or benign and diagnose their BI-RADS category assessment with a score from 2
to 6 and their shape as oval, round, lobulated or irregular. The results of the proposed methodology showed
the classification performance’s improvement compared to the individual architectures and to the other
methods applied on the existing benchmark datasets. Tab.10 shows that we achieved the highest pathology
classification performance on the two public datasets: CBIS-DDSM with an accuracy of 95.13% and an AUC
score of 0.95, and INbreast with an accuracy of 99.20% and an AUC score of 0.99. Furthermore, we surpassed
the results of other models for the BI-RADS categorization on the CBIS-DDSM dataset with an accuracy of
85.38% and an AUC score of 0.94, and on the INbreast dataset with an accuracy of 99% and an AUC score
of 1.0. We also reported the highest results on the shape classification for the CBIS-DDSM dataset with an
accuracy of 90.02% and an AUC score of 0.98.
Comparing with the similar frameworks that applied the presented classification tasks on segmented
ROI masses, our model outperformed the MobileNet and NasNet models [129] for the pathology
classification on the CBIS-DDSM dataset and the Ensemble of AlexNet-based CNN model [150] on the
INbreast dataset. Moreover, the shape classification achieved better results on a similar dataset DDSM that
was evaluated with an individual CNN model [149]. As a result, the stacking model technique provided an
efficient way to learn from various depths of neural networks and combine them in another neural network
classifier model to benefit from the different weights that were trained individually. Limitations of the
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proposed methodology can occur on the long training time of 0.74s per epoch, which is due to the high
number of trainable parameters and computations of the ResNetV2 model.
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CHAPTER V
CONCLUSION & FUTURE WORKS

In this dissertation, we proposed an integrated framework for Computer-aided Diagnosis (CAD)
system that is based on deep learning techniques. The system will serve as a second-reading tool to help
doctors investigating the risk of breast cancer and provide an advanced analysis for the suspicious lesions.
The presented work proposed three main steps to process a mammogram to first detect the location of
abnormalities and distinguish their types to either Mass, Calcification, or Architectural distortion, etc. Next,
the system focused on Mass lesions in mammograms and generated a precise contour of the Mass tumors to
help determining their malignancy and grading score. Consequently, the ROI of masses were segmented to
mask the tissue background and highlight the tumor. Finally, the integrated system predicted the pathology
of the detected tumors and classified their BI-RADS score and shape.
The first step was conducted with a YOLO-based fusion model and presented a method that
overcomes the problem of predicting location and type of two common abnormal findings in the entire
mammograms: Mass and Calcification. Results showed the capability of our proposed methodology to
accurately achieve state-of-the-art performance. In addition, the dissertation provided feasible and promising
results using the proposed fusion models approach that was considered to join different models and lower the
miss-prediction error.
Moreover, as the breast lesions detection plays a critical role in the CAD systems and fully integrated
breast cancer diagnosis our methodology provided an improved detection performance compared with the
recent deep learning models. This helps to prevent making additional mistakes when diagnosing the lesions
that have been found. Furthermore, the second step provided a novel architecture to segment the breast
masses in mammograms. The proposed architecture incorporated the recent modifications that were
suggested to overcome the challenges of pixel-to-pixel segmentation in medical images, such as attention

114

mechanism, residual blocks, ASPP concept, etc. The improved segmentation performance was made after
benefiting from the information decoded using one UNet and propagated again to a second UNet. In addition,
synthetic data was developed to supplement the training data using the CycleGAN model. This uses a quality
translation across domains to account for the various quality levels of current mammography datasets (such
as X-ray filter and full-field digital mammography (FFDM)).
Finally, the third step integrated our recent works of the YOLO-based fusion models [175] and the
Connected-UNets model [176] that generated the detected and segmented ROIs of breast masses. The final
diagnosis step was suggested using a stacked ensemble of Neural network models (ResNets) to predict the
pathology (malignant or benign), the BI-RADS grading score (2 to 6), and the pathology (round, oval,
lobulated, irregular) to provide an entire framework for breast cancer diagnosis that may also include clinical
reports analysis. Indeed, an increase of performance using the segmented ROIs has indicated the advantage
of masking the background tissues from the tumors’ boundaries to help improve the overall classification
and diagnosis and decrease the false positive and negative rates.
In summary, this dissertation presents the integrated framework for a breast cancer CAD system via
deep learning models. The three stages of detection, segmentation and classification aim to provide a
complete clinical tool that can assist radiologists with a second suggestion for an automated mass tumor
diagnosis.
Future works can include combining different mammography datasets and improving the long
training of deep learning models for the three tasks. Potential ideas may include integrating more
abnormalities to the entire system such as Calcification and Architectural distortion and upgrade the
segmentation and classification with more annotated datasets.
More orientations to the future could include the radiology reports and medical text data and merge them
within the images data for more precision and affordable explainability to the AI and machine learning for
medical applications.
This work aimed to focus on mammography images for breast cancer analysis and diagnosis, but
we believe it can be transferred to other medical imaging application such Lung cancer, Pulmonary diseases,
Brain cancer, etc. Moreover, the proposed architecture models were designed for 2D medical images such
mammograms, but we may be reconstructed for 3D medical images such as CT and MRI.
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